<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1038/s41467-019-10823-8</query><apiKey>6b19ee21fe6a243741a528650f7c8997</apiKey><result><total>1</total><start>1</start><pageLength>1</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="research-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><?properties open_access?><front><journal-meta><journal-id journal-id-type="publisher-id">41467</journal-id><journal-title-group><journal-title>Nature Communications</journal-title><abbrev-journal-title abbrev-type="publisher">Nat Commun</abbrev-journal-title></journal-title-group><issn pub-type="epub">2041-1723</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s41467-019-10823-8</article-id><article-id pub-id-type="manuscript">10823</article-id><article-id pub-id-type="doi">10.1038/s41467-019-10823-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group><subj-group subj-group-type="SubjectPath"><subject>/631/1647/2210</subject></subj-group><subj-group subj-group-type="SubjectPath"><subject>/631/208/176/2016</subject></subj-group><subj-group subj-group-type="SubjectPath"><subject>/631/326/417/1716</subject></subj-group><subj-group subj-group-type="SubjectPath"><subject>/631/326/417/2550</subject></subj-group><subj-group subj-group-type="TechniquePath"><subject>/14/19</subject></subj-group><subj-group subj-group-type="TechniquePath"><subject>/38/15</subject></subj-group><subj-group subj-group-type="TechniquePath"><subject>/38/23</subject></subj-group><subj-group subj-group-type="TechniquePath"><subject>/82/58</subject></subj-group><subj-group subj-group-type="TechniquePath"><subject>/38/89</subject></subj-group><subj-group subj-group-type="TechniquePath"><subject>/38/91</subject></subj-group><subj-group subj-group-type="NatureArticleTypeID"><subject>article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Monoallelic expression and epigenetic inheritance sustained by a <italic>Trypanosoma brucei</italic> variant surface glycoprotein exclusion complex</article-title></title-group><contrib-group><contrib contrib-type="author" id="Au1"><name><surname>Faria</surname><given-names>Joana</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au2"><name><surname>Glover</surname><given-names>Lucy</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au3"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3895-0282</contrib-id><name><surname>Hutchinson</surname><given-names>Sebastian</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" id="Au4"><name><surname>Boehm</surname><given-names>Cordula</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au5"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4866-2885</contrib-id><name><surname>Field</surname><given-names>Mark C.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au6"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5173-9284</contrib-id><name><surname>Horn</surname><given-names>David</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="corresp" rid="IDs41467019108238_cor6">f</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0397 2876</institution-id><institution-id institution-id-type="GRID">grid.8241.f</institution-id><institution content-type="org-division">The Wellcome Trust Centre for Anti-Infectives Research, School of Life Sciences</institution><institution content-type="org-name">University of Dundee</institution></institution-wrap><addr-line content-type="street">Dow Street</addr-line><addr-line content-type="postcode">DD1 5EH</addr-line><addr-line content-type="city">Dundee</addr-line><country country="GB">UK</country></aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2353 6535</institution-id><institution-id institution-id-type="GRID">grid.428999.7</institution-id><institution content-type="org-division">Trypanosome Molecular Biology, Department of Parasites and Insect Vectors</institution><institution content-type="org-name">Institut Pasteur</institution></institution-wrap><addr-line content-type="street">25-28 Rue du Docteur Roux</addr-line><addr-line content-type="postcode">75015</addr-line><addr-line content-type="city">Paris</addr-line><country country="FR">France</country></aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2353 6535</institution-id><institution-id institution-id-type="GRID">grid.428999.7</institution-id><institution content-type="org-division">Trypanosome Cell Biology Unit, INSERM U1201, Department of Parasites and Insect Vectors</institution><institution content-type="org-name">Institut Pasteur</institution></institution-wrap><addr-line content-type="street">25-28 Rue du Docteur Roux</addr-line><addr-line content-type="postcode">75015</addr-line><addr-line content-type="city">Paris</addr-line><country country="FR">France</country></aff></contrib-group><author-notes><corresp id="IDs41467019108238_cor6"><label>f</label><email>d.horn@dundee.ac.uk</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>9</day><month>7</month><year>2019</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>12</month><year>2019</year></pub-date><volume>10</volume><issue seq="20198188">1</issue><elocation-id>3023</elocation-id><history><date date-type="registration"><day>5</day><month>6</month><year>2019</year></date><date date-type="received"><day>23</day><month>10</month><year>2018</year></date><date date-type="accepted"><day>4</day><month>6</month><year>2019</year></date><date date-type="online"><day>9</day><month>7</month><year>2019</year></date></history><permissions><copyright-statement>© The Author(s) 2019</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="url">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1" xml:lang="en"><title>Abstract</title><p id="Par1">The largest gene families in eukaryotes are subject to allelic exclusion, but mechanisms underpinning single allele selection and inheritance remain unclear. Here, we describe a protein complex sustaining variant surface glycoprotein (<italic>VSG</italic>) allelic exclusion and antigenic variation in <italic>Trypanosoma brucei</italic> parasites. The <italic>VSG-</italic>exclusion-1 (VEX1) protein binds both telomeric <italic>VSG</italic>-associated chromatin and VEX2, an ortholog of nonsense-mediated-decay helicase, UPF1. VEX1 and VEX2 assemble in an RNA polymerase-I transcription-dependent manner and sustain the active, subtelomeric <italic>VSG</italic>-associated transcription compartment. <italic>VSG</italic> transcripts and VSG coats become highly heterogeneous when VEX proteins are depleted. Further, the DNA replication-associated chromatin assembly factor, CAF-1, binds to and specifically maintains VEX1 compartmentalisation following DNA replication. Thus, the VEX-complex controls <italic>VSG</italic>-exclusion, while CAF-1 sustains VEX-complex inheritance in association with the active-<italic>VSG</italic>. Notably, the VEX2-orthologue and CAF-1 in mammals are also implicated in exclusion and inheritance functions. In trypanosomes, these factors sustain a highly effective and paradigmatic immune evasion strategy.</p></abstract><abstract id="Abs2" xml:lang="en"><p id="Par2">Monoallelic expression of variant surface glycoprotein genes (<italic>VSGs</italic>) is essential for immune evasion by <italic>Trypanosoma brucei</italic>. Here, Faria <italic>et al</italic>. show that the VEX protein complex controls <italic>VSG</italic> allelic exclusion, and that CAF‐1 sustains inheritance of the VEX‐complex in association with the active <italic>VSG</italic>.</p></abstract><funding-group><award-group><funding-source><institution-wrap><institution>Wellcome Trust (Wellcome)</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">https://doi.org/10.13039/100004440</institution-id></institution-wrap></funding-source><award-id award-type="FundRef grant">100320/Z/12/Z</award-id><principal-award-recipient><name><surname>Horn</surname><given-names>David</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>Nature Research</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>1</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>The Author(s)</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>Yes</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>6</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>5</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>NonStandardArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/41467_2019_Article_10823.pdf</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>OriginalPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Science, Humanities and Social Sciences, multidisciplinary</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Science, Humanities and Social Sciences, multidisciplinary</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Science, multidisciplinary</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Science (multidisciplinary)</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par3">Antigenic variation and host immune evasion by parasites causing malaria<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>, giardiasis<sup><xref ref-type="bibr" rid="CR2">2</xref></sup> and African trypanosomiasis<sup><xref ref-type="bibr" rid="CR3">3</xref></sup> depend upon monoallelic and switchable variant surface antigen expression. Indeed, allelic exclusion governs the expression of many of the largest known gene-families, typically encoding cell-surface proteins in protozoa and mammals, and has major impacts on health and disease. In mammals, odour detection depends upon olfactory receptor exclusion<sup><xref ref-type="bibr" rid="CR4">4</xref></sup> and B- and T-cell specificity depends upon immunoglobulin and surface receptor exclusion, respectively<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Selection of a single allele from a large gene family is thought to be inherently stochastic rather than deterministic and generates tremendous cellular diversity, upon which adaptive mechanisms operate. Notably, the diversity-generating exclusion systems of protozoan antigenic variation, and the host immune response, are mutually adaptive and in direct competition. Despite intense study, the molecular mechanisms facilitating the selection and maintenance of a single active allele, coordinated with heritable exclusion of all others, remain poorly understood.</p><p id="Par4">The African trypanosome, <italic>Trypanosoma brucei</italic>, is transmitted among mammalian hosts by tsetse-flies and, due to effective immune evasion, causes chronic and lethal infections, specifically sleeping-sickness in humans and nagana in cattle. In these parasites RNA polymerase-I (pol-I) transcribes a single, dominant, telomeric variant surface glycoprotein (<italic>VSG</italic>) gene<sup><xref ref-type="bibr" rid="CR3">3</xref></sup> as part of a polycistronic transcription unit. Pol-I transcription initiates at several sites but this is attenuated at all but one site<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. <italic>T. brucei</italic> can switch to activate a new telomeric <italic>VSG</italic> expression site (ESs) but, significantly, switching occurs at low-frequency and all but one of the ESs typically remain ‘silent’, despite possessing all <italic>cis</italic>-elements required for expression<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>.</p><p id="Par5">The active <italic>VSG</italic>-ES is associated with an extranucleolar pol-I transcription factory, known as the expression site body (ESB)<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>. This <italic>VSG</italic>-ES is depleted of nucleosomes<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup> and nuclease-hypersensitive chromatin persists at this locus even if transcription is blocked<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. An HMG chromatin protein is enriched at both the ESB and the nucleolus<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup>, and a focus of SUMOylation associates with the ESB<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. In addition, histones<sup><xref ref-type="bibr" rid="CR15">15</xref></sup> and histone variants<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>, telomere-binding proteins, a histone H3-K76 methyltransferase, a histone deacetylase, a chromatin remodeler, histone chaperones, nuclear lamina components, cohesin and the inositol phosphate pathway all impact <italic>VSG</italic>-ES silencing to varying degrees (reviewed in ref. <sup><xref ref-type="bibr" rid="CR17">17</xref></sup>). These factors may impact chromatin-dependent silencing or transcriptional permissivity but, notably, a direct role in gene selection has not been demonstrated. More recently, the first factor specifically enriched in association with the active <italic>VSG</italic>-ES, VSG exclusion 1 (VEX1), was identified<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>.</p><p id="Par6">Here, we identify and characterise a VEX1–VEX2 complex. The complex assembles a sub-nuclear domain in a transcription-dependent manner and maintains <italic>VSG</italic> allelic exclusion by negatively controlling transcription of other telomeric <italic>VSGs</italic>. Inheritance of <italic>VSG</italic> exclusion requires maintenance of the VEX-complex during S-phase, which depends upon the conserved chromatin assembly factor, CAF-1.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>A subtelomere- and <italic>VSG</italic>-associated VEX-complex</title><p id="Par7">We previously described <italic>T. brucei</italic> VEX1 (Tb927.11.16920), the only known protein specifically enriched in association with the ESB<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. VEX1, therefore, is at the heart of the nuclear subdomain meditating antigenic variation in trypanosomes, but VEX1 lacks orthologs in other cell types, it remained unclear why <italic>VSG</italic>-exclusion was only partially perturbed following VEX1-knockdown and it remained unclear whether other factors were involved in <italic>VSG</italic>-exclusion.</p><p id="Par8">To identify VEX1 chromatin interactions, we affinity-purified VEX1<sup>myc</sup>-associated chromatin and deep-sequenced the enriched DNA. Reads were accurately aligned to individual <italic>VSG</italic>-ESs by uniqueness filtering, using MapQ &gt; 1<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. An examination of protein coding sequences within the hemizygous subtelomeric <italic>VSG-</italic>ESs<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR19">19</xref></sup> revealed <italic>VSG-2</italic>, the active <italic>VSG</italic>, as the most enriched gene (Fig. <xref rid="Fig1" ref-type="fig">1a</xref>, Supplementary Data <xref ref-type="supplementary-material" rid="MOESM5">1</xref>, sheet 1). We also observed particularly strong enrichment of the region downstream of this gene (Fig. <xref rid="Fig1" ref-type="fig">1a</xref>). This is consistent with a focus of VEX1 that is adjacent to, rather than coincident with, the extranucleolar focus of pol-I at the active <italic>VSG</italic>-ES<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. Notably, DNA immediately downstream of several silent ES-associated <italic>VSGs</italic> was also enriched (Fig. <xref rid="Fig1" ref-type="fig">1a</xref>, Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">1</xref>). This is also consistent with our model proposing that conserved <italic>VSG</italic>-associated sequences, including the telomeric repeats, participate in VEX1- and homology-dependent <italic>VSG</italic>-silencing<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. Thus, chromatin interactions connect VEX1 to the conserved sequences associated with telomeric <italic>VSGs</italic>.<fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><p>A subtelomere- and <italic>VSG</italic>-associated VEX-complex. <bold>a</bold> Affinity purification of VEX1<sup>myc</sup>-associated chromatin followed by sequencing (ChIP-seq). Enrichment traces over active (<italic>VSG-2</italic>) and silent (<italic>VSG-6</italic>, <italic>VSG-13</italic>) <italic>VSG</italic>-ESs with 1 kbp non-overlapping bins; red circles, promoters; red boxes, <italic>VSGs</italic>; grey boxes, expression-site associated genes (<italic>ESAGs</italic>). Box-plot depicting enrichment of the indicated CDSs. Centre lines show the medians; box limits indicate the 25th and 75th percentiles; whiskers extend from the 10th to the 90th percentile, outliers are shown. Silent <italic>VSGs</italic>, <italic>n</italic> = 18; <italic>ESAGs</italic>, <italic>n</italic> = 129. Metagene plot and the associated heat-map for active and silent telomeric <italic>VSGs</italic>. The red bar on the metagene plot indicates the location of a highly conserved sequence in the <italic>VSG</italic> 3’-untranslated region. <bold>b</bold> VEX1<sup>GFP</sup> immunoprecipitation and proteomics. GFP-tag dependent enrichment from bloodstream form <italic>T. brucei</italic>. emPAI, exponentially modified protein abundance index. The inset shows immunoprecipitates and tag-dependent VEX1 (red) and VEX2 (green) bands highlighted in a silver-stained gel. <bold>c</bold> Schematic representation of VEX1 (Tb927.11.16920), VEX2 (Tb927.11.13380) and CAF-1 subunits (a, Tb927.8.3980; b, Tb927.10.7050; c, Tb927.11.4970) indicating conserved domains and motifs. <bold>d</bold> Immunofluorescence analysis during the cell cycle and protein-blot analysis of <sup>myc</sup>VEX2 expression. N nucleus; K kinetoplast (mitochondrial genome). <bold>e</bold>, <bold>f</bold> Immunofluorescence-based colocalisation studies of VEX2<sup>GFP</sup> and VEX1<sup>myc</sup> (<bold>e</bold>) or a nucleolar (No) and ESB marker (pol-I, largest subunit), a nucleolar marker (NOG1) or Histone H3 (<bold>f</bold>). In <bold>e</bold>, G1 or G2 cells are shown. <bold>d</bold>–<bold>f</bold> DNA was counter-stained with DAPI; the images correspond to maximal 3D projections of 0.1 μm stacks; scale bars 2 μm; the data are representative of independent biological replicates and independent experiments. Source data are provided as a Source Data file</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/41467_2019_10823_Fig1_HTML.png"/></p></fig></p><p id="Par9">Next, we affinity-purified VEX1<sup>GFP</sup>-associated proteins using cryomilling and high-affinity nanobodies. The procedure was carried out initially in insect-stage <italic>T. brucei</italic> (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">2a, b</xref>), for which protocols were established<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>, and then in bloodstream form <italic>T. brucei</italic> (Fig. <xref rid="Fig1" ref-type="fig">1b</xref>). Quantitative proteomic analysis (Fig. <xref rid="Fig1" ref-type="fig">1b</xref>, Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">2a, b</xref>, Supplementary Data <xref ref-type="supplementary-material" rid="MOESM5">1</xref>, sheet 2) revealed tag-dependent enrichment of green flourescent protein (GFP) and the same set of five proteins in four independent experiments; VEX1 was enriched, as expected, but also Tb927.11.13380, an ortholog of the nonsense-mediated mRNA-decay ATP-dependent superfamily 1-type helicases, UPF1/SMG2/NAM7/Rent1<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>, (Fig. <xref rid="Fig1" ref-type="fig">1c</xref>, Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">2c–e</xref>), now designated VEX2 (predicted 224 kDa, 2026 residues). Trypanosomes encode two UPF1-related proteins (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">2c</xref>). The putative <italic>T. brucei</italic> canonical UPF1 has been studied but it remains unclear whether classical nonsense-mediated decay operates<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. VEX2 contains a UPF1-related helicase domain towards the <italic>C</italic>-terminus, including the canonical motifs involved in ATP binding and hydrolysis and nucleic acid binding (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">2d</xref>). Structural prediction suggested the presence of an α-solenoid architecture at the <italic>N</italic>-terminus (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">2e</xref>), in place of the typical UPF2-interacting domain<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>; α-solenoids are frequently involved in protein–protein or protein–RNA interactions. The other three proteins that displayed tag-dependent enrichment were all three components of chromatin assembly factor 1 (CAF-1; CAF-1a, Tb927.8.3980; CAF-1b, Tb927.10.7050, CAF-1c, Tb927.11.4970; Fig. <xref rid="Fig1" ref-type="fig">1b, c</xref>, Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">2a</xref>), the evolutionary conserved hetero-trimeric replication-associated histone chaperone<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. Notably, no pol-I components were enriched.</p><p id="Par10">Super-resolution fluorescence microscopy revealed that, like VEX1, VEX2 localised to a single major sub-nuclear focus (detected in ~80% of nuclei) that was replicated and segregated at the appropriate phases of the cell cycle (Fig. <xref rid="Fig1" ref-type="fig">1d</xref>). Consistent with the proteomics evidence, VEX2-foci co-localised with VEX1 foci (Fig. <xref rid="Fig1" ref-type="fig">1e</xref>, Supplementary Movie <xref ref-type="supplementary-material" rid="MOESM6">1</xref>) and the extranucleolar, histone-depleted pol-I compartment (Fig. <xref rid="Fig1" ref-type="fig">1f</xref>). We conclude that the VEX1–VEX2-complex is associated with the single <italic>VSG</italic> transcription compartment.</p></sec><sec id="Sec4"><title>VEX-complex compartmentalisation is transcription-dependent</title><p id="Par11">VEX1 foci are disrupted in cells treated with transcription inhibitors, indicating that active transcription is required for assembly<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>. However, it was unclear from these studies whether VEX1 was degraded or redistributed throughout the nucleoplasm. Protein blotting indicated that neither VEX1 (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>) nor VEX2 (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>) were degraded following pol-I specific transcription inhibition with BMH-21. Indeed, super-resolution confocal microscopy revealed that both VEX1 (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>, Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">3a</xref>) and VEX2 (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>, Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">3b</xref>) displayed significant levels of redistribution across the nucleus following inhibition of pol-I transcription, or inhibition of general transcription with actinomycin D (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">3c–f</xref>). Thus, recruitment of VEX1 and VEX2 to the <italic>VSG</italic> transcription compartment requires active pol-I transcription. VEX1 and VEX2 proteins remain within the nucleus when transcription is prevented, suggesting availability for retargeting once pol-I transcription reinitiates.<fig id="Fig2"><label>Fig. 2</label><caption xml:lang="en"><p>VEX-complex compartmentalisation is transcription dependent. <bold>a</bold>, <bold>b</bold> Protein-blot and immunofluorescence analysis of VEX1<sup>myc</sup> (<bold>a</bold>) and <sup>myc</sup>VEX2 (<bold>b</bold>) before and after BMH-21 treatment (30 min at 1 μM). Proportions of nuclei displaying 1–2 major foci or distributed signals are indicated; the remaining cells displayed no detectable signal. Values are averages of two independent experiments (≥100 nuclei each). Error bars, SD; **<italic>p</italic> &lt; 0.01; ***<italic>p</italic> <italic>&lt;</italic> 0.001 (two-tailed paired Student’s <italic>t</italic> test). DNA was counter-stained with DAPI; the images correspond to maximal 3D projections of 0.1 μm stacks; scale bars 2 μm; the data are representative of independent biological replicates and independent experiments. Source data are provided as a Source Data file</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/41467_2019_10823_Fig2_HTML.png"/></p></fig></p></sec><sec id="Sec5"><title>VEX2 depletion results in multi-VSG expression</title><p id="Par12">VEX1 was initially identified from a high-throughput RNA interference (RNAi) screen for subtelomeric loss-of-silencing<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. Another genome-wide RNAi screen indicated minimal fitness-cost following VEX1-knockdown, but a significant and major fitness-cost following VEX2-knockdown, specifically in bloodstream-form cells and not insect-stage cells<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">4a</xref>). This likely explains why only VEX1, and not VEX2, was identified in the loss-of-silencing screen, and indicates a bloodstream-form specific function for VEX2; VSG is not normally expressed in the insect-stage.</p><p id="Par13">To explore the function of VEX2, we assembled three independent inducible RNAi knockdown strains with an active <italic>VSG-2</italic> expression site (Fig. <xref rid="Fig3" ref-type="fig">3</xref>, Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">4b</xref>). Knockdown was associated with a significant growth defect (Fig. <xref rid="Fig3" ref-type="fig">3a</xref>), but little perturbation of cell cycle distribution (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">4c</xref>). In these cells, normally silent <italic>VSG-6</italic> was strongly derepressed after only 24 h, as assessed by protein immunoblotting (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>), immunofluorescence microscopy (Fig. <xref rid="Fig3" ref-type="fig">3c</xref>) and immunostaining followed by flow cytometry (Fig. <xref rid="Fig3" ref-type="fig">3d</xref>). Notably, abundance of the initially active VSG was also clearly reduced after 48 h of VEX2-knockdown (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>) and VSG-6 appeared to accumulate in intracellular compartments as well as at the surface (Fig. <xref rid="Fig3" ref-type="fig">3c</xref>, right-hand side). To survey additional VSGs, we used quantitative proteomics of proteins released from the cell-surface. The active VSG on wild-type cells, VSG-2, displayed a relative abundance of 99.9%. Following VEX2-knockdown, VSG-2 remained the most abundant VSG, but VSG-6 and several additional ES-associated VSGs were derepressed (Fig. <xref rid="Fig3" ref-type="fig">3e</xref>, Supplementary Data <xref ref-type="supplementary-material" rid="MOESM5">1</xref>, sheet 3). Because antigenic variation occurs at low frequency, <italic>T. brucei</italic> clones are typically homogeneous and express a single VSG (Fig. <xref rid="Fig3" ref-type="fig">3c–e</xref>). Following VEX2-knockdown, however, &gt;90% of cells simultaneously expressed VSG-2, and VSG-6 at the cell surface as determined by microscopy (Fig. <xref rid="Fig3" ref-type="fig">3c</xref>) and flow cytometry (Fig. <xref rid="Fig3" ref-type="fig">3d</xref>). Taken together, these results indicate major disruption of allelic exclusion and the simultaneous expression of multiple VSGs on the surface of individual cells following VEX2-knockdown.<fig id="Fig3"><label>Fig. 3</label><caption xml:lang="en"><p>VEX2 depletion results in multi-VSG expression. <bold>a</bold> Cumulative growth following tetracycline (Tet) induced VEX2-knockdown; *<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.01 (multiple <italic>t</italic> tests). Protein blotting (<bold>b</bold>), immunofluorescence analysis (<bold>c</bold>), and flow cytometry (<bold>d</bold>), to assess <italic>VSG</italic> expression following VEX2-knockdown (24 h). EF1α, loading-control in (<bold>b</bold>); in <bold>c</bold>, DNA was counter-stained with DAPI and the graph depicts the rapid increase of dual VSG expressing cells following VEX2 knockdown by microscopy analysis. Scale bars, 5 μm (left hand side) and 2 μm (right hand side). Percentages in <bold>d</bold> indicate double-positive cells. <bold>e</bold> Quantitative mass spectrometry analysis of surface-VSGs following VEX2-knockdown (48 h). The inset shows data for wild-type cells. emPAI, exponentially modified Protein Abundance Index. Error bars (not visible in <bold>a</bold>), SD; data are averages from two (<bold>a</bold>/<bold>c</bold>/<bold>e</bold>) independent biological replicates and representative of independent experiments (<bold>a</bold>–<bold>d</bold>). Source data are provided as a Source Data file</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/41467_2019_10823_Fig3_HTML.png"/></p></fig></p></sec><sec id="Sec6"><title>VEX2 coordinates allele-specific <italic>VSG-ES</italic> transcription</title><p id="Par14">To further explore gene expression defects following VEX2-knockdown, we analysed the transcriptome, comparing three independent knockdown strains to three wild-type sub-clones (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">5</xref>, Supplementary Data <xref ref-type="supplementary-material" rid="MOESM5">1</xref>, sheets 4–5). Since RNAi may not degrade the entire mRNA, we show efficient disruption of <italic>VEX2</italic> transcript in Fig. <xref rid="Fig4" ref-type="fig">4a</xref>. Among approximately 7600 genes encoded in the genome, 166 displayed &gt;5-fold and significantly (<italic>p</italic> &lt; 10<sup>−2</sup>) increased expression after 24 h knockdown (Fig. <xref rid="Fig4" ref-type="fig">4b–e</xref>), including every known pol-I transcribed protein-coding locus. There are 18 known silent, telomeric, pol-I promoter-associated <italic>VSGs</italic> in the genome; 13 in polycistronic expression sites and 5 in monocistronic expression sites, with the latter only normally activated in metacyclic cells in the insect salivary gland<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. Total transcript abundance from this full set of 18 <italic>VSGs</italic> (Fig. <xref rid="Fig4" ref-type="fig">4b, c</xref>), and 130 silent expression-site associated genes (<italic>ESAGs</italic>) (Fig. <xref rid="Fig4" ref-type="fig">4d</xref>), was increased by 212 and 32-fold, respectively. Even the <italic>ESAGs</italic> at the active transcribed locus (<italic>n</italic> = 18) were significantly (<italic>p</italic> &lt; 10<sup>−50</sup>) upregulated (9-fold, Fig. <xref rid="Fig4" ref-type="fig">4d</xref>), as were the non-telomeric, pol-I transcribed <italic>procyclin</italic> (associated) genes (Fig. <xref rid="Fig4" ref-type="fig">4e</xref>); <italic>procyclin</italic> genes produce abundant surface proteins that are normally expressed only in insect mid-gut stage cells. Highlighting the magnitude of the VEX2-knockdown phenotype, derepressed <italic>VSGs</italic> contributed &gt;24% of total <italic>VSG</italic> transcripts, compared to only 0.1% in control cells (Supplementary Data <xref ref-type="supplementary-material" rid="MOESM5">1</xref>, sheets 4–5); the super-abundant active <italic>VSG</italic> mRNA is &gt;200-fold more abundant than the average mRNA encoding ribosomal proteins. Notably, several previously silent <italic>VSGs</italic> in ESs with dual promoters (<italic>VSG-6, 8, 15</italic> and <italic>17</italic>; see ref. <sup><xref ref-type="bibr" rid="CR7">7</xref></sup>) were particularly derepressed and produced the four most abundant cellular mRNAs, after <italic>VSG-2</italic>; these VSGs were also readily detected at the cell-surface following VEX2-knockdown (Fig. <xref rid="Fig3" ref-type="fig">3e</xref>). The same <italic>VSG</italic>-ESs were activated at high rates during VSG switching<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. Thus, an additional <italic>VSG</italic>-ES promoter likely facilitates the derepression or activation of a <italic>VSG</italic>-ES. We conclude that VEX2 coordinates <italic>VSG</italic> allelic exclusion and has a profound impact on differential <italic>VSG</italic> expression.<fig id="Fig4"><label>Fig. 4</label><caption xml:lang="en"><p>VEX2 coordinates allele-specific <italic>VSG-ES</italic> transcription. <bold>a</bold>–<bold>e</bold> RNA-seq analysis following VEX2-knockdown (24 h). Total number of reads at <italic>VEX2</italic> locus in the parental population or following <italic>VEX2</italic> RNAi (target fragment indicated) (<bold>a</bold>). <bold>b</bold>–<bold>e</bold> Values are averages from three independent RNAi strains relative to wild-type controls and numbers in brackets indicate increase in transcript abundance for each gene cohort. Red square, <italic>VSG-2</italic>; black circle, <italic>VEX2</italic>. Lower panels show transcript abundance at the silent <italic>VSG-6</italic>, active <italic>VSG-2</italic> and procyclin loci, respectively. Red circles, promoters; red boxes, <italic>VSGs</italic>; grey boxes, other genes. RPKM/RPM, reads per (kilobase per) million. <bold>f</bold> Immunofluorescence and protein-blot analysis of pol-I expression and localisation following VEX2 RNAi. The bar graph indicates the proportion of nuclei (<italic>n</italic> ≥ 100) with nucleolar and/or extranucleolar pol-I signals; the remaining cells displayed no detectable signal. DNA was counter-stained with DAPI; the images correspond to maximal 3D projections of 0.1 μm stacks; scale bars 2 μm. Error bar, SD; *<italic>p</italic> &lt; 0.05; **<italic>p</italic> <italic>&lt;</italic> 0.01 (two-tailed paired Student’s <italic>t</italic> test); data are averages from three independent biological replicates and representative of independent experiments. Source data are provided as a Source Data file</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/41467_2019_10823_Fig4_HTML.png"/></p></fig></p><p id="Par15">We did not anticipate increased expression of <italic>ESAGs</italic> at the active <italic>VSG</italic>-ES in response to VEX2-knockdown (Fig. <xref rid="Fig4" ref-type="fig">4d</xref>). However, it has long been known that <italic>ESAGs</italic> upstream of <italic>VSGs</italic>, despite co-transcription in the same polycistron, yield far less abundant transcripts, and no factor responsible for this differential control had been identified previously; <italic>VSG</italic> mRNA is &gt;140-fold more abundant than the mean <italic>ESAG</italic> mRNA<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. Our transcriptome analysis now indicates post- or co-transcriptional suppression of these <italic>ESAGs</italic> mediated by VEX2. We speculate, based on sequence similarity of VEX2 to UPF1, that negative control by VEX2 may be related to nonsense-mediated mRNA-decay.</p><p id="Par16">We next asked what impact VEX2-knockdown and <italic>VSG</italic>-ES derepression had on RNA pol-I localisation. Immunofluorescence microscopy revealed a remarkable loss of the nucleolar pol-I signal after only 24 h of knockdown and a substantial loss of detectable extranucleolar pol-I foci; protein blotting indicated that pol-I was still present following VEX2 knockdown (Fig. <xref rid="Fig4" ref-type="fig">4f</xref>). These results suggest that derepressed <italic>VSG</italic>-ESs deplete the nucleolus and the ESB of pol-I, redistributing the polymerase to multiple extranucleolar sites.</p></sec><sec id="Sec7"><title>VEX-complex knockdown yields a severe exclusion defect</title><p id="Par17">VEX1 knockdown yielded a moderate <italic>VSG</italic> derepression defect<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> relative to the VEX2 knockdown phenotype (Figs. <xref rid="Fig3" ref-type="fig">3</xref> and <xref rid="Fig4" ref-type="fig">4</xref>). We, therefore, knocked down both VEX1 and VEX2 simultaneously and carried out a similar analysis to that described above. VEX1–VEX2 double knockdown was associated with a very severe growth defect that was cytocidal after 72 h (Fig. <xref rid="Fig5" ref-type="fig">5a</xref>). In these cells, silent <italic>VSG-6</italic> was again strongly derepressed, as assessed by protein immunoblotting; the active-VSG signal was once again clearly reduced after 48 h of knockdown (Fig. <xref rid="Fig5" ref-type="fig">5b</xref>). Following 48 h of VEX1–VEX2 double knockdown, immunofluorescence microscopy revealed that almost all cells expressed both VSG-2 and VSG-6, while &gt;20% of cells simultaneously expressed VSG-2, VSG-6 and VSG-3 (Fig. <xref rid="Fig5" ref-type="fig">5c</xref>); VSG-13 was also expressed by &gt;20% of these cells (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">6a</xref>). We further monitored VEX1-knockdown cells over an extended period, during which cells remain viable<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. This revealed &gt;25% of the population expressing both VSG-2 and VSG-6 throughout the time-course, with no evidence for switching to VSG-6 expression (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">6b</xref>). Thus, VEX-complex knockdown disrupts allelic exclusion and does not simply increase the VSG switching rate. Quantitative proteomic analysis following VEX1–VEX2 knockdown revealed derepression of 15 pol-I promoter-associated VSGs (Fig. <xref rid="Fig5" ref-type="fig">5d</xref>, Supplementary Data <xref ref-type="supplementary-material" rid="MOESM5">1</xref>, sheet 3). A comparison of relative VSG expression revealed that derepressed VSGs contributed approx. 40% of total VSG following VEX1–VEX2 knockdown (Fig. <xref rid="Fig5" ref-type="fig">5e</xref>, Supplementary Data <xref ref-type="supplementary-material" rid="MOESM5">1</xref>, sheet 3) compared to only approximately 10% of total VSG following VEX2 knockdown. As for VEX2-knockdown (Fig. <xref rid="Fig4" ref-type="fig">4f</xref>), double knockdown was associated with loss of both the nucleolar pol-I signal and detectable extranucleolar pol-I foci (Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">6c</xref>).<fig id="Fig5"><label>Fig. 5</label><caption xml:lang="en"><p>VEX-complex knockdown yields a severe exclusion defect. <bold>a</bold> Cumulative growth following tetracycline (Tet) induced VEX1-VEX2 double knockdown; *<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.01 (multiple <italic>t</italic> tests). Protein blotting (<bold>b</bold>), and immunofluorescence analysis (<bold>c</bold>), to assess <italic>VSG</italic> expression following VEX1–VEX2 double knockdown (24 h). Other details as in Fig. <xref rid="Fig3" ref-type="fig">3a–c</xref>. In <bold>c</bold>, an additional silent VSG, VSG-3, was analysed. <bold>d</bold> Quantitative mass spectrometry analysis of surface-VSGs following VEX1-VEX2 double knockdown (48 h). The inset shows data for wild-type cells. <bold>e</bold> Relative abundance of surface-VSGs following VEX2 or VEX1/VEX2-knockdown (48 h). emPAI, exponentially modified Protein Abundance Index (<bold>d</bold>, <bold>e</bold>). Data are averages from two independent biological replicates (<bold>a</bold>, <bold>c</bold>–<bold>e</bold>) and representative of independent experiments (<bold>a</bold>–<bold>c</bold>). Error bars, SD. <bold>f</bold>–<bold>j</bold> RNA-seq analysis following VEX1–VEX2 double knockdown (24 h). Total number of reads across <italic>VEX1</italic> and <italic>VEX2</italic> loci in the parental population or following knockdown (<bold>f</bold>). In <bold>g</bold>–<bold>j</bold> specific cohorts of genes are highlighted and values are averages from three independent RNAi strains relative to wild-type controls. Numbers in square brackets indicate increase in total transcript abundance for each category; RPKM, reads per kilobase per million. Source data are provided as a Source Data file</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/41467_2019_10823_Fig5_HTML.png"/></p></fig></p><p id="Par18">Transcriptome analysis following VEX1–VEX2 knockdown (Fig. <xref rid="Fig5" ref-type="fig">5f</xref>, Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">7</xref>, Supplementary Data <xref ref-type="supplementary-material" rid="MOESM5">1</xref>, sheets 4–5) revealed a similar pattern of derepression as observed above for VEX2 knockdown alone (Fig. <xref rid="Fig5" ref-type="fig">5g–j</xref>). Again, all known pol-I transcribed protein-coding loci were derepressed, and previously silent <italic>VSGs</italic> linked to dual <italic>VSG</italic>-ES promoters produced the four most abundant cellular mRNAs, after <italic>VSG-2</italic> (Fig. <xref rid="Fig5" ref-type="fig">5g</xref>). These data demonstrate that the VEX-complex coordinates <italic>VSG</italic> allelic exclusion. The allelic exclusion system collapses following depletion of the VEX-complex, yielding multi-<italic>VSG</italic> expression, highly heterogeneous VSG coats and cell-death.</p></sec><sec id="Sec8"><title>VEX-complex interactions impact abundance and location</title><p id="Par19">We next asked what impact VEX1 and VEX2 have on each other. VEX1-knockdown had no detectable impact on VEX2 expression or focal localisation (Fig. <xref rid="Fig6" ref-type="fig">6a</xref>). In contrast, VEX1 over-expression substantially diminished VEX2 abundance; VEX1 was highly overexpressed in most nuclei (~80%) and VEX2 foci were no longer detectable by immunofluorescence (Fig. <xref rid="Fig6" ref-type="fig">6b</xref>). These data likely explain the previously reported more severe <italic>VSG</italic> derepression phenotype following VEX1 over-expression compared with knockdown<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> and also indicate that VEX1 can limit VEX2 abundance; this latter feature may be important for preventing activation of a second <italic>VSG</italic>. We also tested the impact of VEX2-knockdown on VEX1 localisation and found that VEX1 was redistributed across multiple sub-nuclear puncta following loss of VEX2 (Fig. <xref rid="Fig6" ref-type="fig">6c</xref>). Thus, VEX1 association with the <italic>VSG</italic> transcription compartment is VEX2-dependent.<fig id="Fig6"><label>Fig. 6</label><caption xml:lang="en"><p>VEX-complex interactions impact abundance and location. <bold>a</bold>, <bold>b</bold> Protein-blot and immunofluorescence analysis following Tet-induced VEX1 knockdown and Tet-induced <sup>myc</sup>VEX1 overexpression, respectively (48 h). In the upper immunofluorescence panels, cells were stained with α-VSG-2 and α-VSG-6 to confirm the dual VSG expression phenotypes reported previously<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. In the lower panels, cells were stained with α-myc for VEX2 localisation (<bold>a</bold>) or both α-myc and α-GFP for VEX1 and VEX2 localisation, respectively (<bold>b</bold>). The bar graphs indicate the proportion of ≥300 nuclei with 1–2 <sup>myc</sup>VEX2 foci following 48 h of VEX1 knockdown (<bold>a</bold>) or with 1–2 <sup>GFP</sup>VEX2 foci following 48 h of VEX1 overexpression (<bold>b</bold>). The proportion of nuclei displaying a distributed VEX1 signal (due to overexpression) is also shown in <bold>b</bold>; the remaining cells displayed no detectable signal. <bold>c</bold> Protein-blot and immunofluorescence analysis of VEX1<sup>Myc</sup> following Tet-induced VEX2 knockdown (24 h). The bar graph indicates the proportion of nuclei with 1–2 VEX1<sup>myc</sup> foci or distributed signal, the remaining cells displayed no detectable signal. The bean-plot shows signal intensity in ≥100 nuclei with 1–2 major VEX1<sup>myc</sup> foci (−Tet) or nuclei with a distributed signal (+Tet 24 h) following VEX2 knockdown. Black lines show the medians; pink/red lines represent individual data points; polygons represent the estimated density of the data. CTNF corrected total nuclear fluorescence, normalised to the nuclear area. EF1α was used as a loading-control. DNA was counter-stained with DAPI; scale bars 2 μm. The images in (<bold>c</bold>) correspond to maximal 3D projections of 0.1 μm stacks. For bar graphs, data representative of independent experiments and averages from two independent biological replicates; error bars, SD. ns, non-significant; *<italic>p</italic> &lt; 0.05; ***<italic>p</italic> &lt; 0.001; ****<italic>p</italic> &lt; 0.0001 (two-tailed paired and unpaired Student’s <italic>t</italic> tests applied to bar graphs and bean plot, respectively). Source data are provided as a Source Data file</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/41467_2019_10823_Fig6_HTML.png"/></p></fig></p></sec><sec id="Sec9"><title>VEX-complex compartmentalisation is stage-specific</title><p id="Par20">Insect-stage <italic>T. brucei</italic> cells neither transcribe <italic>VSG</italic> nor exhibit allelic exclusion. Since we show above that VEX-complex association with the <italic>VSG</italic> transcription compartment requires pol-I transcription, we asked whether VEX2 association with this compartment is absent in insect-stage cells. Like VEX1<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, VEX2 was indeed redistributed through the nuclear compartment during differentiation (Fig. <xref rid="Fig7" ref-type="fig">7a</xref>). Protein blotting revealed substantial upregulation of VEX2 as the VSG signal diminished (Fig. <xref rid="Fig7" ref-type="fig">7a</xref>) and these differentiated cells displayed multiple VEX2-foci, some of which were coincident with VEX1-foci (Fig. <xref rid="Fig7" ref-type="fig">7b</xref>). Redistributed VEX2 was similarly observed in long-term established insect-stage cells. Thus, both VEX1 and VEX2 associate with the <italic>VSG</italic> transcription compartment in a pol-I transcription-dependent and life cycle stage-specific manner.<fig id="Fig7"><label>Fig. 7</label><caption xml:lang="en"><p>VEX-complex compartmentalisation is stage-specific. <bold>a</bold> Immunofluorescence and protein-blot analysis of <sup>myc</sup>VEX2 localisation and expression, respectively, following differentiation of bloodstream forms (BSFs, 0 h) into procyclic forms (PCFs). As immunofluorescence control, the cells were stained for the major surface glycoprotein for each developmental stage; VSG in BSFs and EP-procyclin in PCFs. For protein blotting, EF1α was used as a loading-control. <bold>b</bold><sup>GFP</sup>VEX2/VEX1<sup>myc</sup> colocalisation studies in 48 h differentiated BSFs. In <bold>b</bold>, these images correspond to maximal 3D projections of 0.1 μm stacks. DNA was counter-stained with DAPI; scale bars 2 μm. Data representative of independent experiments. Source data are provided as a Source Data file</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/41467_2019_10823_Fig7_HTML.png"/></p></fig></p></sec><sec id="Sec10"><title>Colocalisation of CAF-1 and the VEX-complex during S phase</title><p id="Par21">We next considered the interaction between the VEX-complex and CAF-1; all three components of this conserved chromatin chaperone were co-immunoprecipitated with VEX1 (see Fig. <xref rid="Fig1" ref-type="fig">1b</xref>). DNA replication presents both an opportunity to retain or reset epigenetic states. We, therefore, asked if CAF-1 plays a role in the inheritance of the VEX-complex-dependent epigenetic state during DNA replication; the active <italic>VSG</italic>-ES is replicated early during S-phase while the silent <italic>VSG</italic>-ESs are replicated later<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. Significantly, S-phase specific <italic>VSG-</italic>ES derepression was previously reported following CAF-1b knockdown<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>. By analysing the localisation of a tagged CAF-1b subunit, either CAF-1b<sup>GFP</sup> or CAF-1b<sup>myc</sup>, we observed major CAF-1b foci, despite an overall punctate nuclear distribution. Notably, these foci co-localised with the sub-nuclear compartment defined by both VEX1 (Fig. <xref rid="Fig8" ref-type="fig">8a</xref>, Supplementary Movie <xref ref-type="supplementary-material" rid="MOESM7">2</xref>) and VEX2 (Fig. <xref rid="Fig8" ref-type="fig">8b</xref>) and coincident signals were significantly enriched in S-phase cells (Fig. <xref rid="Fig8" ref-type="fig">8a, b</xref>); the interaction between the VEX-complex and CAF-1 was also confirmed by immunoprecipitation followed by protein blotting (Fig. <xref rid="Fig8" ref-type="fig">8c</xref>).<fig id="Fig8"><label>Fig. 8</label><caption xml:lang="en"><p>Colocalisation of CAF-1 and the VEX-complex during S phase. <bold>a</bold>, <bold>b</bold> Immunofluorescence-based colocalisation studies of VEX1<sup>myc</sup>/CAF-1b<sup>GFP</sup> and VEX2<sup>GFP</sup>/CAF-1b<sup>myc</sup>. Representative images from G1 and S phase cells are shown. Nuclei (<italic>n</italic> ≥ 70) were scored for CAF-1b puncta coincident with VEX1<sup>myc</sup>/VEX2<sup>GFP</sup> foci. DNA was counter-stained with DAPI; scale bars, 2 μm. Error bars, SD; *<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.01; ***<italic>p</italic> &lt; 0.001 (one-way ANOVA test). Values are averages from two independent biological replicates and are representative of independent experiments. The images on the right-hand side correspond to maximal 3D projections of 0.1 μm stacks. <bold>c</bold> Co-immunoprecipitation of VEX2<sup>GFP</sup>/CAF-1b<sup>myc</sup> followed by protein-blot analysis. Green circle, GFP; black circles, myc; I, input; E, elution. Source data are provided as a Source Data file</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/41467_2019_10823_Fig8_HTML.png"/></p></fig></p></sec><sec id="Sec11"><title>VEX-complex reassembly and inheritance requires CAF-1</title><p id="Par22">By analysing phenotypes associated with CAF-1b knockdown, we confirmed two further specific predictions in support of CAF-1 dependent inheritance of the VEX-complex. First, VEX1 distributed across multiple sub-nuclear puncta following CAF-1b knockdown (12 h, Fig. <xref rid="Fig9" ref-type="fig">9a</xref>); while VEX2 notably remained primarily compartmentalised in a single focus in each nucleus under the same conditions (Fig. <xref rid="Fig9" ref-type="fig">9b</xref>). Indeed, we observed more intense VEX2 foci following CAF-1b knockdown, and protein blotting confirmed that VEX2 abundance is specifically increased when CAF-1b is depleted (Fig. <xref rid="Fig9" ref-type="fig">9c</xref>, Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">8a, b</xref>). Thus, CAF-1 limits VEX2 abundance, an effect that may be enhanced by excess VEX1 (see above). Second, following CAF-1b knockdown (see Fig. <xref rid="Fig9" ref-type="fig">9d</xref>), transcriptome analysis revealed specific derepression of <italic>VSGs</italic> and other pol-I transcribed protein-coding genes (Fig. <xref rid="Fig9" ref-type="fig">9e–i</xref>, Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">8c, d</xref>, Supplementary Data <xref ref-type="supplementary-material" rid="MOESM5">1</xref>, sheets 4–5).<fig id="Fig9"><label>Fig. 9</label><caption xml:lang="en"><p>VEX-complex reassembly and inheritance requires CAF-1. VEX1<sup>myc</sup> (<bold>a</bold>), but not <sup>myc</sup>VEX2 (<bold>b</bold>), is distributed following tetracycline (Tet) induced CAF-1b knockdown (12 h), as assessed by immunofluorescence analysis. DNA was counter-stained with DAPI; scale bars, 2 μm. The images correspond to maximal 3D projections of 0.1 μm stacks. Error bars, SD; ns, not significant; **<italic>p</italic> &lt; 0.01 (two-tailed paired Student’s <italic>t</italic> test). Values are averages from three independent biological replicates and are representative of independent experiments (the remaining cells displayed no detectable signal). <bold>c</bold> Protein-blot analysis of CAF-1b<sup>myc</sup>, <sup>myc</sup>VEX2 and VEX1<sup>myc</sup> expression following CAF-1b knockdown. EF1α was used as a loading-control. <bold>d</bold>–<bold>i</bold> RNA-seq analysis following CAF-1b knockdown (24 h). <bold>d</bold> Total number of reads across <italic>CAF-1b</italic> locus in the parental population or following <italic>CAF-1b</italic> RNAi. <bold>e</bold>–<bold>i</bold> Values are averages from two independent RNAi strains relative to wild-type controls. Panel <bold>e</bold> shows transcript abundance at the silent <italic>VSG-6</italic> ES. Red circles, promoters; red boxes, <italic>VSGs</italic>; grey boxes, other genes. RPKM/RPM, reads per (kilobase per) million (<bold>e</bold>–<bold>i</bold>). Panels <bold>f</bold>–<bold>i</bold> highlight different gene cohorts and numbers in square brackets indicate increase/decrease in total transcript abundance for each category; red square, <italic>VSG-2</italic>; black circle, <italic>CAF-1b</italic>. Promoter-proximal <italic>VSGs</italic> and <italic>ESAGs</italic> (6, 7 and 10) are within 5 kbp of a promoter, distal <italic>VSGs</italic> are 46 +/−4 kbp from the promoter. Source data are provided as a Source Data file</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/41467_2019_10823_Fig9_HTML.png"/></p></fig></p><p id="Par23">Following CAF-1b knockdown for 24 h (see Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">8c</xref>), 115 genes displayed &gt;5-fold and significantly (<italic>p</italic> &lt; 10<sup>−2</sup>) increased expression, &gt;80% of which were also significantly increased following VEX2 knockdown (Supplementary Data <xref ref-type="supplementary-material" rid="MOESM5">1</xref>, sheets 4, 5). In this case, we observed a more pronounced increase in total transcript abundance for promoter-proximal <italic>VSGs</italic> (89-fold, <italic>n</italic> = 5, Fig. <xref rid="Fig9" ref-type="fig">9g</xref>) relative to promoter-distal <italic>VSGs</italic> (9-fold, <italic>n</italic> = 5, Fig. <xref rid="Fig9" ref-type="fig">9g</xref>). Similarly, we observed a more pronounced increase in total transcript abundance for promoter-proximal <italic>ESAGs</italic> (48-fold, <italic>n</italic> = 34, Fig. <xref rid="Fig9" ref-type="fig">9h</xref>) relative to promoter-distal <italic>ESAGs</italic> (4-fold, <italic>n</italic> = 96, Fig. <xref rid="Fig9" ref-type="fig">9h</xref>). <italic>Procyclin</italic> (associated) genes were also derepressed (6-fold, Fig. <xref rid="Fig9" ref-type="fig">9i</xref>), while <italic>ESAGs</italic> at the active locus displayed significantly (<italic>p</italic> &lt; 10<sup>−4</sup>) reduced expression (44 ± 19%, <italic>n</italic> = 12; Fig. <xref rid="Fig9" ref-type="fig">9h</xref>, Supplementary Data <xref ref-type="supplementary-material" rid="MOESM5">1</xref>, sheets 4–5), consistent with increased VEX2 abundance and enhanced VEX2-mediated negative control at this locus (see above). Thus, CAF-1 knockdown has a major impact on pol-I transcribed protein-coding loci; promoter-proximal genes may be particularly susceptible to derepression due to a genome-wide histone chaperone defect.</p></sec><sec id="Sec12"><title>A model for <italic>VSG</italic> allelic exclusion by the VEX-complex</title><p id="Par24">Finally, combining RNA-seq data, we compared the relative contributions of VEX1, VEX2 and CAF1-b to <italic>VSG</italic> silencing (Fig. <xref rid="Fig10" ref-type="fig">10a</xref>) and also calculated relative contributions to an allelic exclusion index; the ratio of reads from the active <italic>VSG</italic> relative to all 18 silent expression-site associated <italic>VSGs</italic> (Fig. <xref rid="Fig10" ref-type="fig">10b</xref>). VEX2 clearly makes the major contribution to <italic>VSG</italic> silencing (Fig. <xref rid="Fig10" ref-type="fig">10a, b</xref>), establishing a 1000-fold expression differential in wild-type cells, which, following VEX2 or VEX-complex depletion, is diminished to a 2–4-fold differential (Fig. <xref rid="Fig10" ref-type="fig">10b</xref>). As illustrated by our model (Fig. <xref rid="Fig10" ref-type="fig">10c</xref>), we conclude that the VEX-complex associates with the active <italic>VSG</italic> in a pol-I transcription-dependent manner and thereby coordinates nuclear pol-I compartments and <italic>VSG</italic> exclusion. VEX1 compartmentalisation is VEX2-dependent, while retention during DNA replication is also CAF-1 dependent.<fig id="Fig10"><label>Fig. 10</label><caption xml:lang="en"><p>A model for <italic>VSG</italic> allelic exclusion by the VEX-complex. <bold>a</bold>, <bold>b</bold> Comparative analysis of <italic>VSG</italic>-transcripts from wild-type <italic>T. brucei</italic> or following VEX1 (data from Glover et al., 2016; dashed boxes), VEX2, VEX1/VEX2 and CAF-1b knockdown (data from current study). <bold>a</bold> The box-plot depicts the sum of silent <italic>VSG</italic> expression; whiskers extend from the minimal to the maximal value, other details as in Fig. <xref rid="Fig1" ref-type="fig">1a</xref>. <bold>b</bold> The allelic exclusion index represents active <italic>VSG-2</italic> expression divided by the expression of all other expression site associated <italic>VSGs</italic> combined. Error bars, SD. <bold>c</bold> A model for heritable exclusion by the VEX-complex and CAF-1. Left-hand panel: <italic>VSG</italic>-ES transcription drives competition for a limited pool of the VEX-complex. Once associated with chromatin, the complex promotes transcription and transmits a silencing signal, excluding other <italic>VSG</italic>-ESs, ultimately allowing only one <italic>VSG</italic>-ES to recruit sufficient pol-I and to form a pol-I transcription compartment. CAF-1 dependent compartmentalisation of the complex provides allele-specific epigenetic inheritance. Middle and right-hand panels: VEX2 or CAF-1 depletion disrupts the VEX-complex associated transcription compartment and the silencing signal; it remains unclear how VEX1 interacts with <italic>VSG</italic>-ESs under these circumstances. Bent arrows and dashed arrows indicate <italic>VSG</italic>-ES promoters and transcription, respectively. Source data are provided as a Source Data file</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/41467_2019_10823_Fig10_HTML.png"/></p></fig></p></sec></sec><sec id="Sec13" sec-type="discussion"><title>Discussion</title><p id="Par25">An improved understanding of immune evasion by pathogens has profound importance to health and disease. Despite intense study, mechanisms underlying stochastic activation of one allele and the heritable exclusion of all others remain to be fully defined. This has been the case for antigenic variation in the parasites that cause malaria<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>, giardiasis<sup><xref ref-type="bibr" rid="CR2">2</xref></sup> and African trypanosomiasis;<sup><xref ref-type="bibr" rid="CR3">3</xref></sup> and also in mammals where olfactory receptor allelic exclusion underpins odour detection<sup><xref ref-type="bibr" rid="CR4">4</xref></sup> and where immunoglobulin and receptor allelic exclusion underpin specificity in B and T cells<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>.</p><p id="Par26">Here, we describe an association between a bipartite VSG exclusion (VEX)-complex and the active <italic>VSG</italic> transcription sub-compartment in <italic>T. brucei</italic>. The complex, which is compartmentalised due to active <italic>VSG</italic>-ES transcription, mediates transcriptional silencing of all other <italic>VSG</italic> alleles (Fig. <xref rid="Fig10" ref-type="fig">10c</xref>). In addition, VEX1 sequestration requires VEX2, and also CAF-1 during DNA replication. Transcription-dependent sequestration, and a major allelic exclusion defect when the VEX-complex is depleted are consistent with a sequestration-transcription based positive-feedback mechanism, favoring sequestration of the VEX-complex at the transcribed <italic>VSG</italic> compartment. This may be important for maintaining, and we speculate, also establishing, allelic exclusion. CAF-1 dependence indicates that inheritance of exclusion requires VEX1 reloading during, or soon after, DNA replication. Notably, the VEX-complex is also present in insect-stage cells, suggesting availability for retargeting once <italic>VSG</italic> transcription reinitiates in parasites in the insect salivary gland.</p><p id="Par27">Several observations suggest potentially shared mechanisms with allelic exclusion in mammals. The VEX2-related UPF1 orthologue in humans (Rent1) influences early nuclear events in mRNA biogenesis, including splicing<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. Mammalian Rent1 is enriched at telomeres and negatively controls the association between telomeric repeat-containing RNA (TERRA) transcripts and chromatin at these sites; it has been proposed that these transcripts promote heterochromatin assembly, similar to <italic>Xist</italic> RNA promotion of X-chromosome inactivation<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. In addition, murine UPF1 is required for X-inactivation and formation of <italic>Xist</italic> RNA domains, a function involving <italic>Xist</italic> splicing control<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. Taken together, these findings suggest a conserved role for this helicase family in regulating lncRNA-chromatin associations, and possibly in gene expression choices. The enrichment of VEX1 and VEX2 in association with the active <italic>VSG</italic>-ES is also reminiscent of nuclear sub-structures in other eukaryotic cells, such as PML bodies and nuclear speckles<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup>.</p><p id="Par28">It remains unclear how the activity state of a gene is reproduced on daughter chromatids following DNA replication. The conserved hetero-trimeric histone H3–H4 specific chaperone, CAF-1, participates in chromatin assembly directly behind the passing DNA polymerase during DNA replication, integrating DNA synthesis with conservative reassembly of chromatin in eukaryotes<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>. This involves reincorporating the majority of maternal histones within 400 bp of their pre-replication locus<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> and locus-specific bookmarking by epigenetic regulatory complexes to maintain transcriptional programs<sup><xref ref-type="bibr" rid="CR36">36</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup>. Mammalian CAF-1 sustains somatic cell types<sup><xref ref-type="bibr" rid="CR38">38</xref></sup> and epigenetic memory by interacting with heterochromatin protein 1α, a histone H3 methyltransferase and KRAB-ZFP-associated protein 1; this complex is also associated with sub-nuclear foci<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. Human CAF-1 can also activate transcription independent of its histone deposition function<sup><xref ref-type="bibr" rid="CR40">40</xref></sup> and the conserved CAF-1 subunit-associated dREAM complex plays a role in specifying and maintaining olfactory receptor gene expression in <italic>Drosophila</italic><sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. Thus, in addition to housekeeping roles in chromatin assembly, several lines of evidence suggest an evolutionary conserved role for CAF-1 in sustaining site-specific molecular memories of epigenetic states. Our findings indicate that this can involve CAF-1 dependent and locus-specific compartmentalisation of non-histone, chromatin-associated regulators as epigenetic marks. Consistent with this view, a cohesin-dependent delay in active <italic>VSG</italic> sister chromatid separation facilitates epigenetic inheritance<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. Thus, premature segregation of sister chromatids following cohesin depletion may yield free VEX1 and present opportunities for activation of other <italic>VSG</italic>-ESs.</p><p id="Par29">VEX2 makes the greatest contribution to differential VSG expression, as assessed at mRNA and protein levels, while loss of both VEX1 and VEX2 leads to collapse of the exclusion system. Transcription sustains VEX-complex assembly at the active locus and this sequestration through transcription may also drive the establishment of a single active site. The VEX-complex may also be self-limiting, in the sense that CAF-1 and VEX1 can negatively control VEX2 expression; this may be important to minimise activation at other sites and hence secure selectivity. We previously demonstrated homology-dependent silencing by VEX1<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> and suspect that communication among <italic>VSG</italic> alleles requires a <italic>trans</italic>-acting RNA component. Although the current findings demonstrate robust negative control of silent <italic>VSGs</italic> by the VEX-complex, a more detailed dissection of the proposed positive and negative controls, and their coordination to achieve allelic exclusion, will require further study.</p><p id="Par30">In summary, the crosstalk among <italic>VSG</italic>-ESs and inheritance of allelic exclusion in trypanosomes requires transcription, the VEX-complex and CAF-1 dependent partitioning of VEX1. These factors collectively sustain a specific assembly in association with the active <italic>VSG</italic>, resulting in exclusion of all other <italic>VSG</italic> alleles. CAF-1 links the VEX-complex to the active site to produce a molecular memory. Our findings reveal the factors underpinning a winner-takes-all paradigm for the establishment, maintenance and inheritance of nuclear bodies and allele-specific epigenetic states. To our knowledge, this is the first characterisation of a protein complex directly responsible for single gene choice in an allelic exclusion system.</p></sec><sec id="Sec14" sec-type="methods"><title>Methods</title><sec id="Sec15"><title><italic>T. brucei</italic> growth and manipulation</title><p id="Par31">Bloodstream-form <italic>T. brucei</italic>, Lister 427 and 2T1 cells<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>, both wild-type with respect to VEX1, VEX2 and CAF-1 subunits, were grown in HMI-11 medium and genetically manipulated using electroporation<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>; cytomix was used for all transfections. Puromycin, phleomycin, hygromycin and blasticidin were used at 2, 2, 2.5 and 10 µg ml<sup>−1</sup> for selection of recombinant clones; and at 1, 1, 1 and 2 µg ml<sup>−1</sup> for maintaining those clones, respectively. Cumulative growth curves were generated from cultures seeded at 10<sup>5</sup> cells ml<sup>−1</sup>, counted on a haemocytometer and diluted back to 10<sup>5</sup> cells ml<sup>−1</sup> as necessary. For differentiation of bloodstream form to procyclic form, 2 × 10<sup>7</sup> cells were resuspended in DTM medium, 2.5 mg ml<sup>−1</sup> of haemin, 300 mM cis-aconitate and incubated at 27 °C. Established procyclic-form <italic>T. brucei</italic>, Lister 427 cells were grown in SDM-79 at 27 °C and genetically manipulated using electroporation as above. Blasticidin was used at 10 and 2 μg ml<sup>−1</sup> for selection and maintenance, respectively.</p></sec><sec id="Sec16"><title>Plasmids</title><p id="Par32">For RNAi, primers were selected from ORF sequences using CLC Viewer v. 7.8 and BLAST analysis to minimise potential off-target effects. A specific RNAi target fragment for VEX2 (Tb927.11.13380, 471 bp) was amplified and cloned into pRPa<sup>iSL</sup><sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. The VEX1 (Tb927.11.16920, 574 bp)<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> and CAF-1b (Tb927.10.7050, 458 bp)<sup><xref ref-type="bibr" rid="CR15">15</xref></sup> RNAi cassettes were excised prior to electroporation by digesting with <italic>Asc</italic>I. For epitope-tagging at the native locus, a 710 bp fragment of VEX2 was amplified and cloned into pNAT<sup>TAGx</sup><sup><xref ref-type="bibr" rid="CR45">45</xref></sup> to add an <italic>N</italic>-terminal 6× c-myc or GFP-tag and a fragment of 918 bp was amplified and cloned into pNAT<sup>xTAG</sup><sup><xref ref-type="bibr" rid="CR45">45</xref></sup> to add a <italic>C</italic>-terminal GFP tag. The vectors were linearised with <italic>Xho</italic>I and <italic>Hpa</italic>I, respectively. The VEX1<sup>12myc</sup><sup><xref ref-type="bibr" rid="CR17">17</xref></sup> and CAF-1b<sup>12myc</sup><sup><xref ref-type="bibr" rid="CR15">15</xref></sup><italic>C</italic>-terminal tagging vectors were linearised with <italic>Sph</italic>I and <italic>Nde</italic>I, respectively. The VEX1 and CAF-1b GFP <italic>C</italic>-terminal tagging vectors were made by replacing the 12× c-myc tag and were also linearised with <italic>Sph</italic>I and <italic>Nde</italic>I, respectively. The VEX1 <italic>C</italic>-terminal myc-tag overexpression cassette<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> was excised prior to electroporation by digesting with <italic>Asc</italic>I. Linearised RNAi and overexpression constructs, under the control of tetracycline-inducible promoters, were transfected into 2T1 cells, which allow for targeting to a single genomic locus validated for robust inducible expression<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>.</p></sec><sec id="Sec17"><title>ChIP-seq</title><p id="Par33">ChIP and cell lysis<sup><xref ref-type="bibr" rid="CR46">46</xref></sup> was carried out with the following modifications. Briefly, 2 × 10<sup>8</sup><italic>T. brucei</italic> bloodstream form cells expressing a <italic>C</italic>-terminal 12-myc tagged endogenous copy of <italic>VEX1</italic> were cross-linked with 1% formaldehyde for 20 min at RT. DNA was sonicated using a Bioruptor (Diagenode) with sonication beads (Diagenode, C01020031) for 5 cycles of 30 s on/30 s off. <italic>C</italic>-terminal 12-myc VEX1 was immunoprecipitated with α-Myc antibody coupled to Dynabeads Protein G (2.8 µm). Antibody coupling to the Dynabeads was carried out according to the manufactures recommendations. The beads were then washed with RIPA buffer (50 mM HEPES-KOH, pKa 7.55, 500 mM LiCl, 1 mM EDTA, 1.0% NP-40, 0.7% Na-Deoxycholate) and eluted DNA was purified by phenol chloroform extraction and ethanol precipitation. Reads were mapped to bloodstream <italic>VSG</italic>-ESs<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> and metacyclic <italic>VSG-</italic>ESs<sup><xref ref-type="bibr" rid="CR47">47</xref>,<xref ref-type="bibr" rid="CR48">48</xref></sup> from the Lister 427 strain. Bowtie 2-mapping<sup><xref ref-type="bibr" rid="CR49">49</xref></sup> was with the parameters --very-sensitive --no-discordant --phred33, and with a MapQ value of &gt;1<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. Alignment files were manipulated with SAMtools<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. Alignments were inspected with the Artemis genome browser<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. Telomeric <italic>VSG</italic> coding sequences with a mapping quality filtering of &gt;1 were aligned using deeptools computeMatrix scale-regions. The bedgraph for log<sub>2</sub> fold change was generated using deepTools2<sup><xref ref-type="bibr" rid="CR52">52</xref></sup> with 1 kb bins and the option smoothLength 5000, plotted in Excel and further assembled in Illustrator. The heat map was generated using deepTools. Reads were counted using BEDTools<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>, counting reads in non-overlapping 1 kb bins. Files were normalised by counting total read counts per library prior to fold change calculation for each bin. Locus maps were generated by exporting vector graphics views or regions of interest from Artemis genome browser and manipulation in Adobe illustrator. The box plot was generated in Graphpad Prism v7.0.</p></sec><sec id="Sec18"><title>Affinity-enrichment of VEX1-interactors</title><p id="Par34">1 × 10<sup>10</sup> insect or bloodstream form <italic>T. brucei</italic> cells with or without a <italic>C</italic>-terminal GFP-tagged endogenous copy of <italic>VEX1</italic> were washed three times in ice cold PBS with protease inhibitors (Roche, EDTA free) and subsequently cryomilled into a fine grindate, in a planetary ball mill (Retsch)<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>; protein–protein interactions are effectively preserved under these conditions. Six aliquots of 50 mg of frozen grindate were thawed into ice cold lysis buffer (20 mM HEPES, pH 7.4, 1 mM MgCl<sub>2</sub>, 10 µM CaCl<sub>2</sub>, protease inhibitor cocktail) containing either 100 mM NaCl or 250 mM citrate and either 0.1% Tween, 0.1% Brij58, 0.1% Triton X-100 or 0.1% Chaps, and pipetted to homogenise. The samples were then subjected to sonication (three pulses at 60% amp) and placed on ice. Samples were spun for 10 min at 20,000<italic>g</italic> at 4 °C to pellet the debris. The supernatant was removed and added to a 1.5 ml eppendorf containing dimeric α-GFP nanobodies<sup><xref ref-type="bibr" rid="CR54">54</xref></sup> conjugated to magnetic beads (Dynabeads—Thermo Scientific) and agitated at 4 °C for 2 h. The samples were then placed on a magnetic rack and washed three times with ice-cold lysis buffer. Samples were eluted with a non-reducing sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) loading buffer or equivalent. The resulting proteins were fractionated by 1D SDS-PAGE and visualised by silver staining.</p></sec><sec id="Sec19"><title>Quantitative mass spectrometry</title><p id="Par35">Affinity-enriched samples were run 2 cm into a NuPAGE<sup>®</sup> Novex Bis–Tris 10% gel with NuPAGE<sup>®</sup> MOPS SDS running buffer (Life Technologies) and subjected to overnight (16 h) trypsin digestion (Modified Sequencing Grade, Roche). Peptides were then extracted, dried in a SpeedVac (Thermo Scientific), resuspended in 50 µl 1% formic acid, centrifuged and transferred to high-performance liquid chromatography (HPLC) vials. 5 µl was typically analysed on a Q Exactive HF Hybrid Quadrupole-Orbitrap Mass Spectrometer (Thermo Scientific) coupled to an UltiMate 3000 RSLCnano ultra HPLC system (Thermo Scientific) and EasySpray column (75 μm × 50 cm, PepMap RSLC C18 column, 2 μm, 100 Å, Thermo Scientific). The mass spectrometer was operated in data dependent mode with a single MS survey scan from 335 to 1800 <italic>m</italic>/<italic>z</italic> followed by 20 sequential <italic>m/z</italic> dependent MS2 scans. The 20 most intense precursor ions were sequentially fragmented by higher energy collision dissociation. The MS1 isolation window was set to 1.4 Da and the resolution set at 60,000. MS2 resolution was set at 15,000. The AGC targets for MS1 and MS2 were set at 3e<sup>6</sup> ions and 2e<sup>5</sup> ions, respectively. The normalised collision energy was set at 27%. The maximum ion injection times for MS1 and MS2 were set at 50 and 19 ms, respectively. The peptides from each fraction were separated using a mix of buffer A (0.1% formic acid in MS grade water) and B (0.08% formic acid in 80% MS grade CH<sub>3</sub>CN) and eluted from the column using a flow rate of 300 nl min<sup>−1</sup> and a linear gradient from 5 to 40% buffer B over 68 min. The column temperature was set at 50 °C. RAW data files were extracted and converted to Mascot generic files (.mgf) using MSC Convert. Data were searched against the MaxQuantTbrucei database using the Mascot Search Engine (Mascot Daemon Version 2.3.2). Fold-change, relative to a sample lacking GFP-tagged VEX1, was used to derive an enrichment score. For VSG analysis, glycosylphosphatidylinositol (GPI)-specific phospholipase C (GPI-PLC) cleaved soluble VSG (sVSG) was prepared and subjected to quantitative mass spectrometry analysis<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR55">55</xref></sup>; the eluate was concentrated on an Amicon Ultra 0.5 ml centrifugal filter (Millipore), and recovered in 100 μl of water. emPAI scores are proportional to protein content in a protein mixture<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>.</p></sec><sec id="Sec20"><title>Co-Immuniprecipitation</title><p id="Par36">4 × 10<sup>8</sup> bloodstream form <italic>T. brucei</italic> cells with or without a <italic>C</italic>-terminal GFP-tagged endogenous copy of <italic>VEX2</italic> and a <italic>C</italic>-terminal 12-myc-tagged endogenous copy of <italic>CAF-1b</italic> were washed three times in ice-cold PBS with protease inhibitors and lysed into ice cold lysis buffer (RIPA, 1 mM DTT, protease inhibitor cocktail). Pipetting to homogenise, 30 s of vortexing and incubation for 30 min at 4 °C facilitated lysis. Samples were spun for 10 min at 20,000<italic>g</italic> at 4 °C to pellet debris. The supernatant was removed and added to a 1.5 ml eppendorf containing α-GFP antibody (Abcam) conjugated to magnetic Dynabeads and agitated at 4 °C for 2 h. The samples were then placed on a magnetic rack and washed five times with ice-cold lysis buffer. Samples were eluted with a reducing NuPAGE LDS loading buffer. The resulting proteins were fractionated by 1D SDS-PAGE and analysed by protein-blotting.</p></sec><sec id="Sec21"><title>Protein blotting</title><p id="Par37">Protein samples were run according to standard protein separation procedures, using SDS-PAGE. However, for VEX2 detection, the use of Bis-Tris gels with a neutral pH environment and a bis–tris/bicine based transfer buffer (containing a reducing agent and 10% methanol) were critical for protein separation and transfer, respectively (NuPAGE, Invitrogen). Otherwise, western blotting was carried out according to standard protocols. The following primary antibodies were used: rabbit α-VEX2 (1:1000), rabbit α-pol-I largest subunit<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> (1:500), rabbit α-VSG-2 (1:20,000), rabbit α-VSG-6 (1:20,000), mouse α-c-myc (Millipore, clone 4A6, 1:7,000), rabbit α-GFP (Abcam, 1:1,000) and mouse α-EF1α (Millipore, clone CBP-KK1, 1:20,000). We used horseradish peroxidase coupled secondary antibodies (α-mouse and α-rabbit, Biorad, 1:2000). Blots were developed using an enhanced chemiluminescence kit (Amersham) according to the manufacturer’s instructions. Densitometry was performed using Fiji v. 2.0.0.</p></sec><sec id="Sec22"><title>Microscopy</title><p id="Par38">Immunofluorescence microscopy was carried out according to standard protocols, using 12-well 5 mm (Thermo Scientific) or 18-well μ-slides (Ibidi) for wide field, and confocal microscopy, respectively. For super-lowest speed; pinhol microscopy, the cells were attached to poly-<sc>l</sc>-lysine treated coverslips (#1.5), stained and only then mounted onto glass slides. For colocalisation studies with pol-I we used antigen-retrieval. Prior to permeabilization, fixed cells were rehydrated in phosphate-buffered saline (PBS) for 5 min at RT, held at 95 °C for 60 s in freshly prepared antigen-retrieval buffer (100 mM Tris, 5% urea, pH 9.5) and then washed 3 × 5 min in PBS at RT. Cells were mounted in Vectashield with DAPI (wide field) or stained with 1 µg ml<sup>−1</sup> DAPI for 10 min and then mounted in Vectashield without DAPI (confocal and super resolution). In <italic>T. brucei</italic>, DAPI-stained nuclear and mitochondrial DNA were used as cytological markers for cell-cycle stage; one nucleus and one kinetoplast (1N:1K) indicates G1, one nucleus and an elongated kinetoplast (1N:eK) indicates S-phase, one nucleus and two kinetoplasts (1N:2K) indicates G2/M and two nuclei and two kinetoplasts (2N:2K) indicates post-mitosis<sup><xref ref-type="bibr" rid="CR57">57</xref>,<xref ref-type="bibr" rid="CR58">58</xref></sup>. Primary antisera were rat α-VSG-2 (1:10,000), rabbit α-VSG-6 (1:10,000), rabbit α-VSG-13<sup><xref ref-type="bibr" rid="CR59">59</xref></sup> (1:5000), mouse α-VSG-3<sup><xref ref-type="bibr" rid="CR60">60</xref></sup> coupled with Alexa 488 (1:500), mouse α-EP procyclin (Cedarlene, 1:1,000), rabbit α-GFP (Invitrogen, 1:250; Abcam, 1:500), mouse α-myc (Source Bioscience, clone 9E10, 1:200 or New England Biolabs, clone 9B11, 1:2,000), rabbit α-pol-I largest subunit<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> (1:100), rabbit α-NOG1<sup><xref ref-type="bibr" rid="CR61">61</xref></sup> (1:500) or rabbit α-histone H3 (Abcam, 1:1000). The secondary antibodies were Alexa Fluor conjugated goat antibodies (Thermo Scientific): α-mouse, α-rat and α-rabbit, AlexaFluor 488 or Alexa Fluor 568 (1:1000 or 1:2000, for confocal or wide field field microscopy, respectively) or α-rat Alexa 647 (1:1000). For the colocalisation studies in Fig. <xref rid="Fig8" ref-type="fig">8a, b</xref> and the quantification in Fig. <xref rid="Fig5" ref-type="fig">5c</xref>, cells were analysed by confocal microscopy, using a Leica TCS SP8 confocal laser scanning microscope and the Leica Application Suite X (LASX) software (Leica, Germany). For the remaining quantifications, cells were analysed by wide field microscopy, using a Zeiss Axiovert 200 M microscope with an AxioCam MRm camera and the ZEN Pro software (Carl Zeiss, Germany). The images were acquired as <italic>z</italic>-stacks (0.1–0.2 µm) and in the case of the wife field microscopy, further deconvolved using the fast iterative algorithm in Zen Pro. For all quantifications, images were acquired with the same settings and equally processed. Corrected total nuclear fluorescence = integrated density − (area of selected nucleus × mean fluorescence of background readings). Representative images were further acquired using a Leica TCS SP8 confocal laser scanning microscope in Hyvolution Mode and the Leica Application Suite X (LASX) software (Leica, Germany). The Hyvolution mode allows super-resolution level images, with settings: highest resolution/lowest speed; pinhole 0.5—Images with DNA in grey (or cyan); Figs. <xref rid="Fig1" ref-type="fig">1</xref>d–f, <xref rid="Fig2" ref-type="fig">2</xref>a, b, <xref rid="Fig3" ref-type="fig">3c</xref> (right hand side) <xref rid="Fig4" ref-type="fig">4</xref>f, <xref rid="Fig5" ref-type="fig">5</xref>c (right hand side), <xref rid="Fig6" ref-type="fig">6</xref>c, <xref rid="Fig7" ref-type="fig">7</xref>b, <xref rid="Fig8" ref-type="fig">8</xref>a, b (right hand side), <xref rid="Fig9" ref-type="fig">9</xref>a, b and Supplementary Fig. <xref ref-type="supplementary-material" rid="MOESM1">3c, d</xref>. All the confocal images (with or without Hyvolution mode) correspond to maximal 3D projections by brightest intensity stacks of approximately 30 slices of 0.1 µm. All the images were processed, scored and the signal quantified using Fiji v. 2.0.0<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>. Actinomycin D was applied at 10 µg ml<sup>−1</sup> for 30 min and pol-I inhibitor (BMH-21) at 1 µM for 30 min, both at 37 °C.</p></sec><sec id="Sec23"><title>Flow cytometry</title><p id="Par39">Flow cytometry was carried out according to standard procedures. The primary antibodies were as follows: rat α-VSG-2 (1:10,000) and rabbit α-VSG-6 (1:10,000). Secondary antibodies were goat α-rat Alexa Fluor 647 and goat α-rabbit Alexa Fluor 488 (both 1:2000). DNA was stained with propidium iodide at 10 µg ml<sup>−1</sup>. Samples were analysed on a BD LSRFortessa (BD Biosciences) and data were visualised using FlowJo software. More than 40,000 events were analysed to determine the percentage of cells in each quadrant.</p></sec><sec id="Sec24"><title>Transcriptome analysis</title><p id="Par40">RNA-seq analysis was performed using 2T1 cells and uninduced or induced clones of VEX2 (24 and 48 h), VEX1/VEX2 (24 and 48 h) or CAF-1b (24 h) RNAi. Briefly, polyadenylated transcripts were enriched using poly-dT beads and reverse-transcribed before sequencing on a HiSeq platform (Illumina). Reads were mapped to a hybrid assembly consisting of the <italic>T. brucei</italic> 927 reference genome plus the bloodstream <italic>VSG</italic>-ESs<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> and metacyclic <italic>VSG-</italic>ESs<sup><xref ref-type="bibr" rid="CR47">47</xref>,<xref ref-type="bibr" rid="CR48">48</xref></sup> from the Lister 427 strain. Bowtie 2-mapping<sup><xref ref-type="bibr" rid="CR49">49</xref></sup> was with the parameters --very-sensitive --no-discordant --phred33. Alignment files were manipulated with SAMtools<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. Per-gene read counts were derived using the Artemis genome browser<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>, MapQ &gt; 1<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. Read counts were normalised using edgeR<sup><xref ref-type="bibr" rid="CR64">64</xref></sup> and differential expression was determined with classic edgeR. RPKM values were derived from normalised read counts in edgeR. Base pair resolution plots were generated using an in-house script.</p></sec><sec id="Sec25"><title>Statistical analysis</title><p id="Par41">All statistical analyses were performed using GraphPad Prism Software (version 7.0), except the transcriptomic analysis (described above). Detailed information regarding replicates, statistical tests and outputs can be found in Supplementary Data <xref ref-type="supplementary-material" rid="MOESM5">1</xref>, sheet 6.</p></sec><sec id="Sec26"><title>Resources and reagents</title><p id="Par42">Details of resources and reagents can be found in Supplementary Data <xref ref-type="supplementary-material" rid="MOESM5">1</xref>, sheet 7. All unique materials are available on request.</p></sec><sec id="Sec27"><title>Reporting summary</title><p id="Par43">Further information on research design is available in the <xref ref-type="supplementary-material" rid="MOESM3">Nature Research Reporting Summary</xref> linked to this article.</p></sec></sec></body><back><ack><title>Acknowledgements</title><p>We thank T. Owen-Hughes, N. Wiechens and V. Singh for assistance with ChIP-seq library preparation; A. Cassidy for Illumina sequencing; R. Clark of the Flow Cytometry and Cell Sorting Facility at the University of Dundee for cell sorting; D. Lamont, K. Beattie and S. Kosto of the FingerPrints Proteomics Facility at the University of Dundee for assistance with quantitative proteomics; the Dundee Imaging Facility<bold>;</bold> J. Rouse for access to the Leica Confocal SP8 Hyvolution microscope; S. Alsford (London School of Hygiene &amp; Tropical Medicine) for the CAF-1 RNAi and CAF-1 tagging constructs; Marilyn Parsons (University of Washington) for the α-NOG1 antisera and C. Marques for discussions. The work was funded by Wellcome Trust Investigator Awards to D.H. [100320/Z/12/Z] and M.C.F. [204697/Z/16/Z] with additional support from a Wellcome Trust Centre Award [203134/Z/16/Z]. The University of Dundee Flow Cytometry and Imaging Facilities are supported by a Wellcome Trust award [097418/Z/11/Z], and the MRC Next Generation Optical Microscopy award [MR/K015869/1], respectively; while both the Proteomics and Imaging Facilities are supported by a Wellcome Trust Technology Platform award [097945/B/11/Z].</p></ack><sec sec-type="author-contribution"><title>Author contributions</title><p>Conceptualisation: J.F., L.G., M.C.F. and D.H. Data curation: J.F. and S.H. Investigation: J.F., L.G. and C.B. Supervision: D.H. Original draft: J.F. and D.H. Review and editing: J.F., L.G., S.H., M.C.F. and D.H.</p></sec><sec sec-type="data-availability"><title>Data availability</title><p>RNA-seq and ChIP-seq data have been deposited in the European Nucleotide Archive <ext-link xlink:href="http://www.ebi.ac.uk/ena" ext-link-type="url">www.ebi.ac.uk/ena</ext-link> (Accession nos. PRJEB21615 and PRJEB25352, respectively). Proteomics data have been deposited in the <italic>PRoteomics</italic> IDEntifications (PRIDE) database <ext-link xlink:href="http://www.ebi.ac.uk/pride" ext-link-type="url">www.ebi.ac.uk/pride</ext-link>, ProteomeXchange accession no. PXD013304. The source data underlying Figs. <xref ref-type="supplementary-material" rid="MOESM8">1</xref>d, <xref ref-type="supplementary-material" rid="MOESM8">2</xref>a, b, <xref ref-type="supplementary-material" rid="MOESM8">3</xref>a–e, <xref ref-type="supplementary-material" rid="MOESM8">4</xref>f, <xref ref-type="supplementary-material" rid="MOESM8">5</xref>a–e, <xref ref-type="supplementary-material" rid="MOESM8">6</xref>a–c, <xref ref-type="supplementary-material" rid="MOESM8">7</xref>a, <xref ref-type="supplementary-material" rid="MOESM8">8</xref>a, b, <xref ref-type="supplementary-material" rid="MOESM8">9</xref>a–c, <xref ref-type="supplementary-material" rid="MOESM8">1</xref>0a, b, Supplementary Figs. <xref ref-type="supplementary-material" rid="MOESM8">3</xref>a–f, <xref ref-type="supplementary-material" rid="MOESM8">4</xref>c, <xref ref-type="supplementary-material" rid="MOESM8">6</xref>a–c, <xref ref-type="supplementary-material" rid="MOESM8">8a, b</xref>, d are provided as a Source Data file.</p></sec><sec sec-type="ethics-statement"><sec id="FPar1" sec-type="COI-statement"><title>Competing interests</title><p id="Par44">The authors declare no competing interests.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guizetti</surname><given-names>J</given-names></name><name><surname>Scherf</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Silence, activate, poise and switch! Mechanisms of antigenic variation in <italic>Plasmodium falciparum</italic></article-title><source>Cell. Microbiol.</source><year>2013</year><volume>15</volume><fpage>718</fpage><lpage>726</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXlslygsbs%3D</pub-id><pub-id pub-id-type="doi">10.1111/cmi.12115</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gargantini</surname><given-names>PR</given-names></name><name><surname>Serradell Mdel</surname><given-names>C</given-names></name><name><surname>Rios</surname><given-names>DN</given-names></name><name><surname>Tenaglia</surname><given-names>AH</given-names></name><name><surname>Lujan</surname><given-names>HD</given-names></name></person-group><article-title xml:lang="en">Antigenic variation in the intestinal parasite <italic>Giardia lamblia</italic></article-title><source>Curr. Opin. Microbiol.</source><year>2016</year><volume>32</volume><fpage>52</fpage><lpage>58</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XnsVemtrs%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.mib.2016.04.017</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horn</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Antigenic variation in African trypanosomes</article-title><source>Mol. Biochem Parasitol.</source><year>2014</year><volume>195</volume><fpage>123</fpage><lpage>129</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXhtVemsbjK</pub-id><pub-id pub-id-type="doi">10.1016/j.molbiopara.2014.05.001</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monahan</surname><given-names>K</given-names></name><name><surname>Lomvardas</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Monoallelic expression of olfactory receptors</article-title><source>Annu Rev. Cell Dev. Biol.</source><year>2015</year><volume>31</volume><fpage>721</fpage><lpage>740</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXhsFShsLvI</pub-id><pub-id pub-id-type="doi">10.1146/annurev-cellbio-100814-125308</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vettermann</surname><given-names>C</given-names></name><name><surname>Schlissel</surname><given-names>MS</given-names></name></person-group><article-title xml:lang="en">Allelic exclusion of immunoglobulin genes: models and mechanisms</article-title><source>Immunol. Rev.</source><year>2010</year><volume>237</volume><fpage>22</fpage><lpage>42</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhtFKrtb%2FK</pub-id><pub-id pub-id-type="doi">10.1111/j.1600-065X.2010.00935.x</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassem</surname><given-names>A</given-names></name><name><surname>Pays</surname><given-names>E</given-names></name><name><surname>Vanhamme</surname><given-names>L</given-names></name></person-group><article-title xml:lang="en">Transcription is initiated on silent variant surface glycoprotein expression sites despite monoallelic expression in <italic>Trypanosoma brucei</italic></article-title><source>Proc. Natl Acad. Sci. USA</source><year>2014</year><volume>111</volume><fpage>8943</fpage><lpage>8948</lpage><pub-id pub-id-type="bibcode">2014PNAS..111.8943K</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXptlKrtb8%3D</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1404873111</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hertz-Fowler</surname><given-names>C</given-names></name><etal/></person-group><article-title xml:lang="en">Telomeric expression sites are highly conserved in <italic>Trypanosoma brucei</italic></article-title><source>PLoS ONE</source><year>2008</year><volume>3</volume><fpage>e3527</fpage><pub-id pub-id-type="bibcode">2008PLoSO...3.3527H</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0003527</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaves</surname><given-names>I</given-names></name><etal/></person-group><article-title xml:lang="en">Subnuclear localization of the active variant surface glycoprotein gene expression site in <italic>Trypanosoma brucei</italic></article-title><source>Proc. Natl Acad. Sci. USA</source><year>1998</year><volume>95</volume><fpage>12328</fpage><lpage>12333</lpage><pub-id pub-id-type="bibcode">1998PNAS...9512328C</pub-id><pub-id pub-id-type="coi">1:CAS:528:DyaK1cXmsl2rt7k%3D</pub-id><pub-id pub-id-type="doi">10.1073/pnas.95.21.12328</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro</surname><given-names>M</given-names></name><name><surname>Gull</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">A pol I transcriptional body associated with <italic>VSG</italic> mono-allelic expression in <italic>Trypanosoma brucei</italic></article-title><source>Nature</source><year>2001</year><volume>414</volume><fpage>759</fpage><lpage>763</lpage><pub-id pub-id-type="bibcode">2001Natur.414..759N</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38Xhtlyjtw%3D%3D</pub-id><pub-id pub-id-type="doi">10.1038/414759a</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Figueiredo</surname><given-names>LM</given-names></name><name><surname>Cross</surname><given-names>GA</given-names></name></person-group><article-title xml:lang="en">Nucleosomes are depleted at the <italic>VSG</italic> expression site transcribed by RNA polymerase I in African trypanosomes</article-title><source>Eukaryot. Cell</source><year>2010</year><volume>9</volume><fpage>148</fpage><lpage>154</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXht1ejt7w%3D</pub-id><pub-id pub-id-type="doi">10.1128/EC.00282-09</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanne</surname><given-names>TM</given-names></name><name><surname>Rudenko</surname><given-names>G</given-names></name></person-group><article-title xml:lang="en">Active <italic>VSG</italic> expression sites in <italic>Trypanosoma brucei</italic> are depleted of nucleosomes</article-title><source>Eukaryot. Cell</source><year>2010</year><volume>9</volume><fpage>136</fpage><lpage>147</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXht1ejt78%3D</pub-id><pub-id pub-id-type="doi">10.1128/EC.00281-09</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aresta-Branco</surname><given-names>F</given-names></name><name><surname>Pimenta</surname><given-names>S</given-names></name><name><surname>Figueiredo</surname><given-names>LM</given-names></name></person-group><article-title xml:lang="en">A transcription-independent epigenetic mechanism is associated with antigenic switching in <italic>Trypanosoma brucei</italic></article-title><source>Nucleic Acids Res.</source><year>2015</year><volume>44</volume><fpage>3131</fpage><lpage>3146</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv1459</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narayanan</surname><given-names>MS</given-names></name><name><surname>Rudenko</surname><given-names>G</given-names></name></person-group><article-title xml:lang="en">TDP1 is an HMG chromatin protein facilitating RNA polymerase I transcription in African trypanosomes</article-title><source>Nucleic Acids Res.</source><year>2013</year><volume>41</volume><fpage>2981</fpage><lpage>2992</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXktF2ktr0%3D</pub-id><pub-id pub-id-type="doi">10.1093/nar/gks1469</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Farfan</surname><given-names>D</given-names></name><name><surname>Bart</surname><given-names>JM</given-names></name><name><surname>Rojas-Barros</surname><given-names>DI</given-names></name><name><surname>Navarro</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">SUMOylation by the E3 ligase TbSIZ1/PIAS1 positively regulates <italic>VSG</italic> expression in <italic>Trypanosoma brucei</italic></article-title><source>PLoS Pathog.</source><year>2014</year><volume>10</volume><fpage>e1004545</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1004545</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alsford</surname><given-names>S</given-names></name><name><surname>Horn</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Cell-cycle-regulated control of <italic>VSG</italic> expression site silencing by histones and histone chaperones ASF1A and CAF-1b in <italic>Trypanosoma brucei</italic></article-title><source>Nucleic Acids Res.</source><year>2012</year><volume>40</volume><fpage>10150</fpage><lpage>10160</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38Xhs1Wqtr3N</pub-id><pub-id pub-id-type="doi">10.1093/nar/gks813</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>LSM</given-names></name><etal/></person-group><article-title xml:lang="en">Genome organization and DNA accessibility control antigenic variation in trypanosomes</article-title><source>Nature</source><year>2018</year><volume>563</volume><fpage>121</fpage><lpage>125</lpage><pub-id pub-id-type="bibcode">2018Natur.563..121M</pub-id><pub-id pub-id-type="doi">10.1038/s41586-018-0619-8</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glover</surname><given-names>L</given-names></name><name><surname>Hutchinson</surname><given-names>S</given-names></name><name><surname>Alsford</surname><given-names>S</given-names></name><name><surname>Horn</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">VEX1 controls the allelic exclusion required for antigenic variation in trypanosomes</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2016</year><volume>113</volume><fpage>7225</fpage><lpage>7230</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28Xos1WqsLY%3D</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1600344113</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutchinson</surname><given-names>S</given-names></name><name><surname>Glover</surname><given-names>L</given-names></name><name><surname>Horn</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">High-resolution analysis of multi-copy variant surface glycoprotein gene expression sites in African trypanosomes</article-title><source>BMC Genom.</source><year>2016</year><volume>17</volume><pub-id pub-id-type="doi">10.1186/s12864-016-3154-8</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callejas</surname><given-names>S</given-names></name><name><surname>Leech</surname><given-names>V</given-names></name><name><surname>Reitter</surname><given-names>C</given-names></name><name><surname>Melville</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Hemizygous subtelomeres of an African trypanosome chromosome may account for over 75% of chromosome length</article-title><source>Genome Res.</source><year>2006</year><volume>16</volume><fpage>1109</fpage><lpage>1118</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XpsFelsrg%3D</pub-id><pub-id pub-id-type="doi">10.1101/gr.5147406</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obado</surname><given-names>SO</given-names></name><name><surname>Field</surname><given-names>MC</given-names></name><name><surname>Chait</surname><given-names>BT</given-names></name><name><surname>Rout</surname><given-names>MP</given-names></name></person-group><article-title xml:lang="en">High-efficiency isolation of nuclear envelope protein complexes from trypanosomes</article-title><source>Methods Mol. Biol.</source><year>2016</year><volume>1411</volume><fpage>67</fpage><lpage>80</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXpsFahtrg%3D</pub-id><pub-id pub-id-type="doi">10.1007/978-1-4939-3530-7_3</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>F</given-names></name><name><surname>Jacobson</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Nonsense-mediated mRNA decay: degradation of defective transcripts is only part of the story</article-title><source>Annu. Rev. Genet.</source><year>2015</year><volume>49</volume><fpage>339</fpage><lpage>366</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXhs1Wqt7fP</pub-id><pub-id pub-id-type="doi">10.1146/annurev-genet-112414-054639</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delhi</surname><given-names>P</given-names></name><name><surname>Queiroz</surname><given-names>R</given-names></name><name><surname>Inchaustegui</surname><given-names>D</given-names></name><name><surname>Carrington</surname><given-names>M</given-names></name><name><surname>Clayton</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Is there a classical nonsense-mediated decay pathway in trypanosomes?</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><fpage>e25112</fpage><pub-id pub-id-type="bibcode">2011PLoSO...625112D</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXhtlSns77K</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0025112</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lykke-Andersen</surname><given-names>S</given-names></name><name><surname>Jensen</surname><given-names>TH</given-names></name></person-group><article-title xml:lang="en">Nonsense-mediated mRNA decay: an intricate machinery that shapes transcriptomes</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2015</year><volume>16</volume><fpage>665</fpage><lpage>677</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXhsFersbvI</pub-id><pub-id pub-id-type="doi">10.1038/nrm4063</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammond</surname><given-names>CM</given-names></name><name><surname>Stromme</surname><given-names>CB</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Patel</surname><given-names>DJ</given-names></name><name><surname>Groth</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Histone chaperone networks shaping chromatin function</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2017</year><volume>18</volume><fpage>141</fpage><lpage>158</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXjs1KhsA%3D%3D</pub-id><pub-id pub-id-type="doi">10.1038/nrm.2016.159</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerry</surname><given-names>LE</given-names></name><etal/></person-group><article-title xml:lang="en">Selective inhibition of RNA polymerase I transcription as a potential approach to treat African trypanosomiasis</article-title><source>PLoS Negl. Trop. Dis.</source><year>2017</year><volume>11</volume><fpage>e0005432</fpage><pub-id pub-id-type="doi">10.1371/journal.pntd.0005432</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alsford</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome</article-title><source>Genome Res.</source><year>2011</year><volume>21</volume><fpage>915</fpage><lpage>924</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXnsFylsr0%3D</pub-id><pub-id pub-id-type="doi">10.1101/gr.115089.110</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aitcheson</surname><given-names>N</given-names></name><etal/></person-group><article-title xml:lang="en">VSG switching in <italic>Trypanosoma brucei</italic>: antigenic variation analysed using RNAi in the absence of immune selection</article-title><source>Mol. Microbiol</source><year>2005</year><volume>57</volume><fpage>1608</fpage><lpage>1622</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXhtVKqsr3L</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2958.2005.04795.x</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">Devlin, R. et al. Mapping replication dynamics in <italic>Trypanosoma brucei</italic> reveals a link with telomere transcription and antigenic variation. <italic>Elife</italic><bold>5</bold>, e12765 (2016).</mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendell</surname><given-names>JT</given-names></name><name><surname>ap Rhys</surname><given-names>CM</given-names></name><name><surname>Dietz</surname><given-names>HC</given-names></name></person-group><article-title xml:lang="en">Separable roles for rent1/hUpf1 in altered splicing and decay of nonsense transcripts</article-title><source>Science</source><year>2002</year><volume>298</volume><fpage>419</fpage><lpage>422</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38Xns12htb8%3D</pub-id><pub-id pub-id-type="doi">10.1126/science.1074428</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azzalin</surname><given-names>CM</given-names></name><name><surname>Reichenbach</surname><given-names>P</given-names></name><name><surname>Khoriauli</surname><given-names>L</given-names></name><name><surname>Giulotto</surname><given-names>E</given-names></name><name><surname>Lingner</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends</article-title><source>Science</source><year>2007</year><volume>318</volume><fpage>798</fpage><lpage>801</lpage><pub-id pub-id-type="bibcode">2007Sci...318..798A</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXht1elsrfM</pub-id><pub-id pub-id-type="doi">10.1126/science.1147182</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciaudo</surname><given-names>C</given-names></name><etal/></person-group><article-title xml:lang="en">Nuclear mRNA degradation pathway(s) are implicated in <italic>Xist</italic> regulation and X chromosome inactivation</article-title><source>PLoS Genet</source><year>2006</year><volume>2</volume><fpage>e94</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.0020094</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hnisz</surname><given-names>D</given-names></name><name><surname>Shrinivas</surname><given-names>K</given-names></name><name><surname>Young</surname><given-names>RA</given-names></name><name><surname>Chakraborty</surname><given-names>AK</given-names></name><name><surname>Sharp</surname><given-names>PA</given-names></name></person-group><article-title xml:lang="en">A phase separation model for transcriptional control</article-title><source>Cell</source><year>2017</year><volume>169</volume><fpage>13</fpage><lpage>23</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXltVWnsrY%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2017.02.007</pub-id></mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunes</surname><given-names>VS</given-names></name><name><surname>Moretti</surname><given-names>NS</given-names></name></person-group><article-title xml:lang="en">Nuclear subcompartments: an overview</article-title><source>Cell Biol. Int.</source><year>2017</year><volume>41</volume><fpage>2</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1002/cbin.10703</pub-id></mixed-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramachandran</surname><given-names>S</given-names></name><name><surname>Henikoff</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Transcriptional regulators compete with nucleosomes post-replication</article-title><source>Cell</source><year>2016</year><volume>165</volume><fpage>580</fpage><lpage>592</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XlslWqtbw%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2016.02.062</pub-id></mixed-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radman-Livaja</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Patterns and mechanisms of ancestral histone protein inheritance in budding yeast</article-title><source>PLoS Biol.</source><year>2011</year><volume>9</volume><fpage>e1001075</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXnsFalsr0%3D</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1001075</pub-id></mixed-citation></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>NJ</given-names></name><name><surname>Follmer</surname><given-names>NE</given-names></name><name><surname>Simon</surname><given-names>MD</given-names></name><name><surname>Aghia</surname><given-names>G</given-names></name><name><surname>Butler</surname><given-names>JD</given-names></name></person-group><article-title xml:lang="en">Polycomb proteins remain bound to chromatin and DNA during DNA replication <italic>in vitro</italic></article-title><source>Cell</source><year>2009</year><volume>137</volume><fpage>110</fpage><lpage>122</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXls1Srsrc%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2009.02.017</pub-id></mixed-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadauke</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">Tissue-specific mitotic bookmarking by hematopoietic transcription factor GATA1</article-title><source>Cell</source><year>2012</year><volume>150</volume><fpage>725</fpage><lpage>737</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38Xht1aksLjF</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2012.06.038</pub-id></mixed-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheloufi</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">The histone chaperone CAF-1 safeguards somatic cell identity</article-title><source>Nature</source><year>2015</year><volume>528</volume><fpage>218</fpage><lpage>224</lpage><pub-id pub-id-type="bibcode">2015Natur.528..218C</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXitVSiurfL</pub-id><pub-id pub-id-type="doi">10.1038/nature15749</pub-id></mixed-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loyola</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">The HP1α-CAF1-SetDB1-containing complex provides H3K9me1 for Suv39-mediated K9me3 in pericentric heterochromatin</article-title><source>EMBO Rep.</source><year>2009</year><volume>10</volume><fpage>769</fpage><lpage>775</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXmvVers7g%3D</pub-id><pub-id pub-id-type="doi">10.1038/embor.2009.90</pub-id></mixed-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SB</given-names></name><name><surname>Ou</surname><given-names>DS</given-names></name><name><surname>Lee</surname><given-names>CF</given-names></name><name><surname>Juan</surname><given-names>LJ</given-names></name></person-group><article-title xml:lang="en">Gene-specific transcriptional activation mediated by the p150 subunit of the chromatin assembly factor 1</article-title><source>J. Biol. Chem.</source><year>2009</year><volume>284</volume><fpage>14040</fpage><lpage>14049</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXlvV2jtLw%3D</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M901833200</pub-id></mixed-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sim</surname><given-names>CK</given-names></name><name><surname>Perry</surname><given-names>S</given-names></name><name><surname>Tharadra</surname><given-names>SK</given-names></name><name><surname>Lipsick</surname><given-names>JS</given-names></name><name><surname>Ray</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Epigenetic regulation of olfactory receptor gene expression by the Myb-MuvB/dREAM complex</article-title><source>Genes Dev.</source><year>2012</year><volume>26</volume><fpage>2483</fpage><lpage>2498</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38Xhslyls7rN</pub-id><pub-id pub-id-type="doi">10.1101/gad.201665.112</pub-id></mixed-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landeira</surname><given-names>D</given-names></name><name><surname>Bart</surname><given-names>JM</given-names></name><name><surname>Van Tyne</surname><given-names>D</given-names></name><name><surname>Navarro</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Cohesin regulates <italic>VSG</italic> monoallelic expression in trypanosomes</article-title><source>J. Cell Biol.</source><year>2009</year><volume>186</volume><fpage>243</fpage><lpage>254</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXpsVGisLs%3D</pub-id><pub-id pub-id-type="doi">10.1083/jcb.200902119</pub-id></mixed-citation></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alsford</surname><given-names>S</given-names></name><name><surname>Kawahara</surname><given-names>T</given-names></name><name><surname>Glover</surname><given-names>L</given-names></name><name><surname>Horn</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Tagging a <italic>T. brucei RRNA</italic> locus improves stable transfection efficiency and circumvents inducible expression position effects</article-title><source>Mol. Biochem. Parasitol.</source><year>2005</year><volume>144</volume><fpage>142</fpage><lpage>148</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXht1Wjtb%2FF</pub-id><pub-id pub-id-type="doi">10.1016/j.molbiopara.2005.08.009</pub-id></mixed-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glover</surname><given-names>L</given-names></name><etal/></person-group><article-title xml:lang="en">Genome-scale RNAi screens for high-throughput phenotyping in bloodstream-form African trypanosomes</article-title><source>Nat. Protoc.</source><year>2015</year><volume>10</volume><fpage>106</fpage><lpage>133</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXitFanu7bF</pub-id><pub-id pub-id-type="doi">10.1038/nprot.2015.005</pub-id></mixed-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alsford</surname><given-names>S</given-names></name><name><surname>Horn</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Single-locus targeting constructs for reliable regulated RNAi and transgene expression in <italic>Trypanosoma brucei</italic></article-title><source>Mol. Biochem. Parasitol.</source><year>2008</year><volume>161</volume><fpage>76</fpage><lpage>79</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXpsVGmtr8%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.molbiopara.2008.05.006</pub-id></mixed-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname><given-names>TN</given-names></name><etal/></person-group><article-title xml:lang="en">Four histone variants mark the boundaries of polycistronic transcription units in <italic>Trypanosoma brucei</italic></article-title><source>Genes Dev.</source><year>2009</year><volume>23</volume><fpage>1063</fpage><lpage>1076</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXmt1Crs7g%3D</pub-id><pub-id pub-id-type="doi">10.1101/gad.1790409</pub-id></mixed-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cross</surname><given-names>GA</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Wickstead</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">Capturing the variant surface glycoprotein repertoire (the VSGnome) of <italic>Trypanosoma brucei</italic> Lister 427</article-title><source>Mol. Biochem. Parasitol.</source><year>2014</year><volume>195</volume><fpage>59</fpage><lpage>73</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXhsVSmt7rP</pub-id><pub-id pub-id-type="doi">10.1016/j.molbiopara.2014.06.004</pub-id></mixed-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolev</surname><given-names>NG</given-names></name><name><surname>Ramey-Butler</surname><given-names>K</given-names></name><name><surname>Cross</surname><given-names>GA</given-names></name><name><surname>Ullu</surname><given-names>E</given-names></name><name><surname>Tschudi</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Developmental progression to infectivity in <italic>Trypanosoma brucei</italic> triggered by an RNA-binding protein</article-title><source>Science</source><year>2012</year><volume>338</volume><fpage>1352</fpage><lpage>1353</lpage><pub-id pub-id-type="bibcode">2012Sci...338.1352K</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XhslKgsLjN</pub-id><pub-id pub-id-type="doi">10.1126/science.1229641</pub-id></mixed-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname><given-names>B</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><article-title xml:lang="en">Fast gapped-read alignment with Bowtie 2</article-title><source>Nat. Methods</source><year>2012</year><volume>9</volume><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38Xjt1Oqt7c%3D</pub-id><pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id></mixed-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><etal/></person-group><article-title xml:lang="en">The sequence alignment/Map format and SAMtools</article-title><source>Bioinformatics</source><year>2009</year><volume>25</volume><fpage>2078</fpage><lpage>2079</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id></mixed-citation></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutherford</surname><given-names>K</given-names></name><etal/></person-group><article-title xml:lang="en">Artemis: sequence visualization and annotation</article-title><source>Bioinformatics</source><year>2000</year><volume>16</volume><fpage>944</fpage><lpage>945</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3MXjvVWksw%3D%3D</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/16.10.944</pub-id></mixed-citation></ref><ref id="CR52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramirez</surname><given-names>F</given-names></name><etal/></person-group><article-title xml:lang="en">deepTools2: a next generation web server for deep-sequencing data analysis</article-title><source>Nucleic Acids Res.</source><year>2016</year><volume>44</volume><fpage>W160</fpage><lpage>W165</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXhtV2itrfI</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkw257</pub-id></mixed-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinlan</surname><given-names>AR</given-names></name><name><surname>Hall</surname><given-names>IM</given-names></name></person-group><article-title xml:lang="en">BEDTools: a flexible suite of utilities for comparing genomic features</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><fpage>841</fpage><lpage>842</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXivFGkurc%3D</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btq033</pub-id></mixed-citation></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fridy</surname><given-names>PC</given-names></name><etal/></person-group><article-title xml:lang="en">A robust pipeline for rapid production of versatile nanobody repertoires</article-title><source>Nat. Methods</source><year>2014</year><volume>11</volume><fpage>1253</fpage><lpage>1260</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXhvVGiurnF</pub-id><pub-id pub-id-type="doi">10.1038/nmeth.3170</pub-id></mixed-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manthri</surname><given-names>S</given-names></name><name><surname>Guther</surname><given-names>ML</given-names></name><name><surname>Izquierdo</surname><given-names>L</given-names></name><name><surname>Acosta-Serrano</surname><given-names>A</given-names></name><name><surname>Ferguson</surname><given-names>MA</given-names></name></person-group><article-title xml:lang="en">Deletion of the <italic>TbALG3</italic> gene demonstrates site-specific <italic>N</italic>-glycosylation and <italic>N</italic>-glycan processing in <italic>Trypanosoma brucei</italic></article-title><source>Glycobiology</source><year>2008</year><volume>18</volume><fpage>367</fpage><lpage>383</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXmsVOqsrc%3D</pub-id><pub-id pub-id-type="doi">10.1093/glycob/cwn014</pub-id></mixed-citation></ref><ref id="CR56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishihama</surname><given-names>Y</given-names></name><etal/></person-group><article-title xml:lang="en">Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein</article-title><source>Mol. Cell Proteom.</source><year>2005</year><volume>4</volume><fpage>1265</fpage><lpage>1272</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXhtVGhu7nL</pub-id><pub-id pub-id-type="doi">10.1074/mcp.M500061-MCP200</pub-id></mixed-citation></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname><given-names>TN</given-names></name><name><surname>Hekstra</surname><given-names>DR</given-names></name><name><surname>Cross</surname><given-names>GA</given-names></name></person-group><article-title xml:lang="en">Analysis of the <italic>Trypanosoma brucei</italic> cell cycle by quantitative DAPI imaging</article-title><source>Mol. Biochem. Parasitol.</source><year>2008</year><volume>160</volume><fpage>171</fpage><lpage>174</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXns1Sntbw%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.molbiopara.2008.04.004</pub-id></mixed-citation></ref><ref id="CR58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodward</surname><given-names>R</given-names></name><name><surname>Gull</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Timing of nuclear and kinetoplast DNA replication and early morphological events in the cell cycle of <italic>Trypanosoma brucei</italic></article-title><source>J. Cell Sci.</source><year>1990</year><volume>95</volume><fpage>49</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">2190996</pub-id></mixed-citation></ref><ref id="CR59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Figueiredo</surname><given-names>LM</given-names></name><name><surname>Janzen</surname><given-names>CJ</given-names></name><name><surname>Cross</surname><given-names>GA</given-names></name></person-group><article-title xml:lang="en">A histone methyltransferase modulates antigenic variation in African trypanosomes</article-title><source>PLoS Biol.</source><year>2008</year><volume>6</volume><fpage>e161</fpage><pub-id pub-id-type="doi">10.1371/journal.pbio.0060161</pub-id></mixed-citation></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinger</surname><given-names>J</given-names></name><name><surname>Chowdhury</surname><given-names>S</given-names></name><name><surname>Papavasiliou</surname><given-names>FN</given-names></name></person-group><article-title xml:lang="en">Variant surface glycoprotein density defines an immune evasion threshold for African trypanosomes undergoing antigenic variation</article-title><source>Nat. Commun.</source><year>2017</year><volume>8</volume><pub-id pub-id-type="bibcode">2017NatCo...8..828P</pub-id><pub-id pub-id-type="doi">10.1038/s41467-017-00959-w</pub-id></mixed-citation></ref><ref id="CR61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Jensen</surname><given-names>BC</given-names></name><name><surname>Kifer</surname><given-names>CT</given-names></name><name><surname>Parsons</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">A novel nucleolar G-protein conserved in eukaryotes</article-title><source>J. Cell Sci.</source><year>2001</year><volume>114</volume><fpage>173</fpage><lpage>185</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3MXhtVSgsLk%3D</pub-id><pub-id pub-id-type="pmid">11112701</pub-id></mixed-citation></ref><ref id="CR62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">Fiji: an open-source platform for biological-image analysis</article-title><source>Nat. Methods</source><year>2012</year><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XhtVKnurbJ</pub-id><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id></mixed-citation></ref><ref id="CR63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carver</surname><given-names>T</given-names></name><name><surname>Harris</surname><given-names>SR</given-names></name><name><surname>Berriman</surname><given-names>M</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><name><surname>McQuillan</surname><given-names>JA</given-names></name></person-group><article-title xml:lang="en">Artemis: an integrated platform for visualization and analysis of high-throughput sequence-based experimental data</article-title><source>Bioinformatics</source><year>2012</year><volume>28</volume><fpage>464</fpage><lpage>469</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38Xis1emsb0%3D</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btr703</pub-id></mixed-citation></ref><ref id="CR64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>MD</given-names></name><name><surname>McCarthy</surname><given-names>DJ</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><article-title xml:lang="en">edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><fpage>139</fpage><lpage>140</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXhs1WlurvO</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id></mixed-citation></ref></ref-list></ref-list><app-group><app id="App1"><sec id="Sec28"><title>Supplementary information</title><p id="Par45"><supplementary-material content-type="local-data" id="MOESM1" xlink:title="Supplementary information"><media xlink:href="MediaObjects/41467_2019_10823_MOESM1_ESM.pdf" mimetype="application" mime-subtype="pdf"><caption xml:lang="en"><p>Supplementary Information</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2" xlink:title="Supplementary information"><media xlink:href="MediaObjects/41467_2019_10823_MOESM2_ESM.pdf" mimetype="application" mime-subtype="pdf"><caption xml:lang="en"><p>Peer Review File</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM3" xlink:title="Supplementary information"><media xlink:href="MediaObjects/41467_2019_10823_MOESM3_ESM.pdf" mimetype="application" mime-subtype="pdf"><caption xml:lang="en"><p>Reporting Summary</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM4" xlink:title="Supplementary information"><media xlink:href="MediaObjects/41467_2019_10823_MOESM4_ESM.pdf" mimetype="application" mime-subtype="pdf"><caption xml:lang="en"><p>Description of Additional Supplementary Files</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM5" xlink:title="Supplementary information"><media xlink:href="MediaObjects/41467_2019_10823_MOESM5_ESM.xlsx" mimetype="application" mime-subtype="vnd.ms-excel"><caption xml:lang="en"><p>Supplementary Data 1</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM6" xlink:title="Supplementary information"><media xlink:href="MediaObjects/41467_2019_10823_MOESM6_ESM.avi" mimetype="video" mime-subtype="x-msvideo"><caption xml:lang="en"><p>Supplementary Movie 1</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM7" xlink:title="Supplementary information"><media xlink:href="MediaObjects/41467_2019_10823_MOESM7_ESM.avi" mimetype="video" mime-subtype="x-msvideo"><caption xml:lang="en"><p>Supplementary Movie 2</p></caption></media></supplementary-material></p></sec><sec id="Sec29"><title>Source Data</title><p id="Par46"><supplementary-material content-type="local-data" id="MOESM8" xlink:title="Source Data"><media xlink:href="MediaObjects/41467_2019_10823_MOESM8_ESM.xlsx" mimetype="application" mime-subtype="vnd.ms-excel"><caption xml:lang="en"><p>Source Data</p></caption></media></supplementary-material></p></sec></app></app-group><notes notes-type="ESMHint"><title>Supplementary information</title><p><bold>Supplementary Information</bold> accompanies this paper at <ext-link xlink:href="https://doi.org/10.1038/s41467-019-10823-8" ext-link-type="doi">https://doi.org/10.1038/s41467-019-10823-8</ext-link>.</p></notes><notes notes-type="Misc"><p><bold>Peer review information:</bold><italic>Nature Communications</italic> thanks Luisa Figueiredo, Sanjeeva Srivastava and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.</p></notes><notes notes-type="Misc"><p><bold>Publisher’s note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></notes></back></article></records><facets><facet name="subject"><facet-value count="1">Science, Humanities and Social Sciences, multidisciplinary</facet-value><facet-value count="1">Science, multidisciplinary</facet-value></facet><facet name="keyword"/><facet name="pub"><facet-value count="1">Nature Communications</facet-value></facet><facet name="year"><facet-value count="1">2019</facet-value></facet><facet name="country"><facet-value count="1">France</facet-value><facet-value count="1">United Kingdom</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
